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Patterns and Predictors of HIV, Sexually Transmitted Infections, and Staphylococcus Aureus Co-
Infection among New York State Prison Inmates 
Nowai L. Keleekai 
 U.S. prisons are overextended, physically restrictive environments. Overcrowding in 
these facilities enhances the transmission of infectious, communicable diseases. At the same 
time, Staphylococcus aureus (S. aureus) colonization and infection rates are elevated in these 
settings. Moreover, HIV and sexually transmitted infections (STIs) are also prevalent. The 
purpose of this cross-sectional, correlational secondary analysis was to describe patterns of S. 
aureus co-infection with HIV and STIs in two New York State prisons and to identify risk 
factors for co-infection. Cultures were obtained from the anterior nares and oropharynx of a 
convenience sample of male (n = 383) and female (n = 373) prisoners in each facility. 
Descriptive and comparative statistics were used to accomplish the study aims. Overall S. aureus 
colonization rate was 53.8%. Among men, the rates of HIV-S. aureus and STI-S. aureus co-
infection were 75% and 45.7%, respectively. Among women, the rates of HIV-S. aureus and 
STI-S. aureus co-infection were 47.4% and 59.1%, respectively. No statistically significant 
differences in S. aureus carriage rates were detected when comparing subjects with and without 
HIV or STIs. Multivariate logistic regression techniques were used to identify predictors of STI-
S. aureus co-infection in women. Insufficient numbers of subjects with HIV and men with STI-S. 
aureus limited regression modeling in these groups. After adjusting for age, race/ethnicity, and 
educational level, only taking more (10.1 vs 8.6) showers each week was significantly associated 
with increased risk of co-infection (p = .04). Results of this study suggested that rates of S. 
 
 
aureus carriage may be uniformly elevated across many risk groups in prisons. Suboptimal 
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 Prevalence and Predictors of HIV, Sexually Transmitted Infections, and Staphylococcus Aureus 
Co-Infection among New York State Prison Inmates 
Chapter 1: Introduction 
Background 
Infection with Staphylococcus aureus (S. aureus), and more specifically, methicillin-
resistant S. aureus (MRSA) has become increasingly more prevalent in community settings. 
Once exclusively associated with hospital and long-term care facilities, MRSA outbreaks have 
been reported in diverse populations such as athletic teams, children attending daycares, and 
prisoners (Adcock, et al., 1998; Campbell, et al., 2004; Centers for Disease Control and 
Prevention, 2003a, 2003b; Herold, et al., 1998; Kazakova, et al., 2005). These populations lack 
the traditional risk factors for MRSA infection, including recent hospitalization and broad-
spectrum antibiotic use (Lowy, 1998; Naimi, et al., 2003).  Moreover, while much attention is 
given to the increasing rates of MRSA, methicillin-susceptible S. aureus (MSSA) is also a 
pathogen capable of causing severe disease in infected individuals (Miller, et al., 2007). 
MRSA has long been a significant cause of morbidity in hospitalized patients and is 
becoming increasingly more widespread (Cosgrove, et al., 2003; Friedman, et al., 2002; Seybold, 
et al., 2006). In 1974, MRSA accounted for 2% of all healthcare-associated S. aureus infections 
(Centers for Disease Control and Prevention, 2010d) a number which reached 64% by 2003 
(Klevens, et al., 2006), highlighting the exponential increase in MRSA prevalence. While MRSA 
continues to plague hospital settings, recent years have seen the emergence of community-
associated MRSA (CA-MRSA) strains among non-hospitalized persons without established risk 
factors for MRSA infection. Recent research has identified a significant number of patients 




community setting (Hidron, et al., 2005). Among the 7% of patients identified as entering the 
hospital colonized with MRSA, significant risk factors for colonization included residence in 
alternative housing, HIV infection, history of MRSA infection/colonization, incarceration, and 
antimicrobial use or hospitalization in the previous 12 months. 
Although the overwhelming majority of CA-MRSA cases involve treatable localized skin 
and soft tissue infections (SSTIs) (Crum, et al., 2006; Crum-Cianflone, et al., 2007; Naimi, et al., 
2003; Ramsetty, et al., 2010), CA-MRSA infection can potentially result in more severe, 
invasive sequealae, including bacteremia, pneumonia, osteomyelitis, endocarditis, and septic 
shock (Klevens, Morrison, et al., 2007). Indeed, according to recent evidence, CA-MRSA 
accounts for 14% of the 19,000 deaths attributed to MRSA infection yearly in the United States 
(Klevens, Edwards, et al., 2007). 
 HIV infection has been identified as an independent risk factor for MRSA colonization 
and infection (Crum-Cianflone, et al., 2007), and it has emerged as a significant cause of concern 
in the HIV-infected population (Popovich et al., 2010). Similar to the general population, these 
CA-MRSA strains most frequently manifest as SSTIs, with dramatic increases in prevalence 
among HIV-infected individuals (Ahuja & Albrecht, 2009; Crum-Cianflone, et al., 2009; Crum-
Cianflone, et al., 2007; Lee, et al., 2005; Shet, et al., 2009; Trinh, et al., 2009). Mathews et al 
(2005) reported a 6-fold increase in CA- MRSA SSTIs among HIV-infected persons between 
2000 and 2003, while others have reported a 17-fold increase in these infections from 2003 to 
2005 (Crum-Cianflone, et al., 2007). Researchers have further calculated MRSA incidence rates 
among persons with HIV between 9 to12 cases per 1000 person years compared to the general 
population rate of 1 to 2 cases per 1000 person years (Crum-Cianflone, et al., 2009; Popovich, et 




individuals. Several behavioral and environmental risk factors have been identified as potential 
predictors of co-infection with MRSA and HIV in the community setting. Among these risk 
factors are advanced immunosuppression, high-risk sexual behavior, injection drug use (IDU), 
antibiotic use, and history of incarceration (Crum-Cianflone, et al., 2007; Lee, et al., 2005; 
Mathews, et al., 2005).  
Similar to trends in the community, rates of MRSA infection in incarcerated populations 
have increased significantly in recent years. In the Texas Department of Criminal Justice, MRSA 
accounted for 24% and 66% of all S. aureus infections in 1998 and 2002 respectively (Centers 
for Disease Control and Prevention, 2003a). Moreover, a study of the Texas prison system 
revealed an incidence rate of 12 MRSA cases per 1000 person years (Baillargeon, Kelley, et al., 
2004). According to this study, the greatest co-morbid risk for MRSA infection was HIV/AIDS. 
Furthermore, a prospective study of HIV-infected outpatients with CA-MRSA revealed that 46% 
of the sample had a history of incarceration (Skiest, et al., 2006). 
 In addition to HIV and MRSA, sexually transmitted infections (STIs) are also common in 
correctional facilities (Flanigan, et al, 2009; Hammett & Drachman-Jones, 2006). Following the 
discontinuation of routine male STI screening in a Chicago jail, the reported cases of chlamydia 
and gonorrhea city-wide among men declined by 33.3% and 19.5%, respectively (Broad, et al., 
2009). This overall decline in STI cases may suggest that the city was unable to capture many 
individuals with STIs by not screening routinely in the selected jail. It follows that a substantial 
percentage of individuals with STIs pass through the correctional system. These data suggest that 
screening in the correctional setting can capture a significant proportion of individuals with STIs 




 A link between STIs and MRSA has also been hypothesized in the literature. Lee and 
colleagues (2005) found, in univariate analysis, that high risk sexual behavior, including multiple 
sex partners, inconsistent condom use, and history of STI, was significantly associated with 
MRSA in a sample of HIV-infected men who have sex with men (MSM). Moreover, history of 
STI was the greatest risk factor (OR 6.4, p = 0.007); however, in multivariate analysis, only 
inconsistent condom use and having a sex partner with skin infection remained significant risk 
factors. While there has been no conclusive evidence, there has been speculation that MRSA 
may act in some ways as an STI based on its transmission mode, i.e., primarily through close 
physical contact. Cook et al (2007) found evidence of heterosexual transmission of MRSA in the 
community where individuals developed colonization and skin infections in the pubic area after 
sexual contact with partners infected with MRSA.   
 The epidemiology of MRSA, HIV and other STIs is similar in that one important route of 
transmission for all three infections is close physical contact, including sexual contact (Cook et 
al., 2007; Crum, et al., 2006; Lee, et al., 2005).  Additionally, HIV in particular results in 
immunosuppression, increasing the likelihood of acquiring other infections.  Hence, it is 
plausible that co-infection with MRSA, HIV and/or other STIs occurs, but the prevalence and 
risk factors have not been widely examined, specifically in a high risk population such as 
prisoners.  
Problem Statement 
While data demonstrating the increased rates of MRSA colonization and infection among 
HIV-infected persons exist, few data are available to support this trend within prison 
populations. No study to date has enumerated the prevalence of either MRSA or MSSA 




demographic and environmental risk factors of prison populations, including increased 
prevalence of HIV, MRSA, poor hygiene, and crowded living conditions would suggest a 
magnification of the MRSA and HIV co-infection rates observed in the civilian population. 
Moreover, as it has been demonstrated that infection with other STIs increases the risk of 
contracting HIV (Fleming & Wasserheit, 1999), it is reasonable to expect elevated rates of STIs 
within a population where HIV is highly prevalent. The research that has been conducted in the 
community population supports the hypothesis that prisoners experience elevated rates of HIV, 
STI and MRSA co-infection. However, none of these hypotheses have been evaluated and 
remain speculative. Examining potential risk factors in this highly susceptible population may 
more clearly elucidate predictors of HIV, STI, and S. aureus co-infection. Targeted surveillance 
and prevention strategies for S. aureus can be developed for high-risk inmates with HIV and 
STIs if the prevalence of co-infection with S. aureus identified within this group is present in the 
prison setting.  
Significance 
According to the most recent data from the U.S. Department of Justice (2010), more than 
1.6 million persons were incarcerated in U.S. prisons at year-end 2009, corresponding to an 
imprisonment rate of 502 prisoners per 100,000 U.S. residents. Moreover, the HIV rate within 
New York state prisons is reported as the highest in U.S. correctional facilities at 5.8% (U.S. 
Department of Justice, 2009).Correctional facilities house a high concentration of individuals 
with multiple factors associated with MRSA, including immunosuppressive conditions and 
injection drug use (Baillargeon, Black, et al., 2004). Additionally, the physical layout of these 
facilities whereby inmates are in close physical contact increases the likelihood of transmission 




share a 10x8 feet cubicle and at Sing Sing Correctional Facility, individual inmates reside in 
10x6 feet cells.  Moreover, in 2008, 729,295 offenders were released from state and federal 
prisons into the community (U.S. Department of Justice, 2010b) and over 153,000 HIV-infected 
persons were released from correctional facilities in 2006 (Spaulding, et al., 2009). Inmates may 
acquire MRSA in prisons and, upon release, transmit the infection to individuals in the 
community who would not otherwise have been exposed to MRSA. This risk of prison-to 
community transmission is heightened if MRSA infections are not identified and effectively 
treated during incarceration (Okano & Blower, 2010). A community-based study in Chicago (n = 
1222) revealed that the presence of HIV and history of incarceration within the previous year 
were significantly associated with CA-MRSA SSTI (Hota, et al., 2007). The large number of 
prisoners released into the community annually underscores the importance of appropriate 
treatment of MRSA among high-risk prisoners and the potential risk to the general public’s 
health that is likely to result from suboptimal treatment.   
Conceptual Framework 
The vulnerable populations model for health-related research developed by Flaskerud & 
Winslow (1998) was the conceptual framework used to guide this study. This model 
conceptualizes relationships among resource availability, relative risk, and health status in 
groups considered to be vulnerable to comparatively poorer health outcomes than the general 
population. In this framework, the locus of responsibility for health is shared between the 
individual and the community in which he lives. Furthermore, the community has the greater 
responsibility to provide the resources, as well as access to these resources, that are conducive to 
favorable health outcomes. For the current study, the three concepts in the model, i.e., resource 




community responsible for the health of its prisoners. Specifically, colonization with S. aureus 
was identified as the primary adverse health outcome and resource availability and relative risk 
were examined in terms of their ability to influence this outcome. This modified model is 
provided in Figure 1. 
Figure 1. Modified Vulnerable Populations Health-Related Research Model for Infectious 































Adapted from Flaskerud, J. H., & Winslow, B. J. (1998). Conceptualizing vulnerable populations health-related research. Nurs 
Res, 47(2), 69-78. 
 
Resource availability was conceptualized as environmental resources that promote health. 
In prison settings, access to resources for adequate infection control, such as alcohol-based hand 
sanitizers and daily showers, are limited primarily to ensure the physical safety of prisoners and 
RESOURCE AVAILABILITY 
↓ access to personal hygiene 
materials 
↓ access to soap/hand 
sanitizers 
↓availability of laundry supplies 
RELATIVE RISK 
Closed environment 
↑ exposure to infectious 
disease 





↑ prevalence of disease: 
STIs, HIV, cardiac disease, 






staff (Bick, 2007). As illustrated in the model, limited resources can negatively influence 
prisoners’ relative risk of contracting infectious diseases, by increasing their exposure to and 
limiting their protection from these diseases. Moreover, the physical environment itself, where 
prisoner movement is restricted and close contact with other prisoners is common, increases the 
risk of acquiring S. aureus. The potential for injury as a result of violence is especially relevant 
as a source of elevated risk for S. aureus. If exposed, prisoners are more susceptible to 
contracting S. aureus when there is a break in the cutaneous barrier. The model also proposes 
that poor health status can deplete an individual’s environmental and social resources by limiting 
access to these resources. 
 The relationship between health status and relative risk is a bi-directional interaction in 
the model, such that both concepts interact to influence each other. Health status is 
conceptualized as morbidity and mortality associated with specific diseases, as well as with 
exposure to multiple risk factors. As an example, HIV rates in prisons are markedly elevated 
(morbidity), which predisposes prisoners to contracting S. aureus as a result of an act of violence 
that may lead to skin trauma (relative risk). In this example, poor health status (HIV) is 
exacerbating the relative risk of contracting S. aureus, while another risk factor (violence) is 
acting to worsen the health status of the individual. This complex interaction between health 
status and relative risk was the primary relationship of interest in this study. The study examined 
the extent to which poor health status, operationalized as STI and HIV infection, in a high risk 







Specific Aims and Hypotheses 
This research aimed to expand knowledge regarding the prevalence of HIV, STI, and S. aureus 
co-infection in a prison population. Using a sample of inmates at two New York State prisons, 
the specific study aims and related hypotheses were to:  
1. Describe the patterns of S. aureus (MSSA and MRSA) co-infection with HIV or 
STIs 
Hypothesis to be tested: The prevalence of HIV-S. aureus and STI-S. aureus co-
infection will be higher than the prevalence of S. aureus among non-HIV infected 
and those without STIs. 
2. Identify risk factors for S. aureus (MSSA and MRSA) co-infection with HIV or 
STIs 
Hypothesis to be tested: Risk factors for HIV-S. aureus and STI-S. aureus co-
infection will be those associated with both poor hygiene practices (e.g., sharing 
of personal items, fewer showers) and high-risk sexual behavior (e.g., multiple 
sex partners, being a man who has sex with men). 
The paucity of literature available in this area combined with the constellation of risk factors for 
HIV, STIs, and S. aureus present in incarcerated populations makes the proposed inquiry both 
timely and relevant.  
This project was a secondary analysis of data from an ongoing investigation in two New 
York State prisons to identify patterns of S. aureus strain transmission within the prison, 
determine the factors associated with the development of clinical infections within the prison, 
and identify risk factors associated with colonization and/or infection with S. aureus at prisoner 





The burden of HIV has been substantial over the past three decades. HIV has evolved 
from a disease primarily affecting MSM to a disease that has touched all demographics across 
the United States. Advancements in HIV treatment, specifically the advent and success of highly 
active antiretroviral therapy (HARRT), have transformed HIV from an acute to chronic illness 
and effectively extended the life expectancy of those living with the disease. Consequently, 
individuals infected with HIV are susceptible to a wide range of other chronic and infectious 
diseases by virtue of their compromised immune system. MRSA is one such infection that 
research suggests disproportionately affects HIV-infected individuals. The literature is replete 
with evidence of increasing rates of MRSA among HIV-infected persons in the community. 
However, prisons represent an important setting where the relationship between HIV and MRSA 
has yet to be studied. Moreover, there has been speculation that MRSA may behave in some 
ways as an STI and may be more prevalent among those individuals infected with or at risk for 
STIs (Cook, et al., 2007; Crum-Cianflone, et al., 2007).  Additionally, due to the potential for 
MSSA to cause significant morbidity in afflicted individuals, it is necessary to not limit 
investigation of S. aureus to MRSA alone. Behavioral risk factors, including IDU and high-risk 
sexual activity as well as environmental risk factors, such as poor hygiene and closed living 
quarters all converge in the prison setting. This convergence of risk factors may serve to 
exacerbate the occurrence of HIV-S. aureus and STI-S. aureus co-infection in incarcerated 






Chapter 2: Review of the Literature 
Introduction 
 This chapter will explore the epidemiology of each of the major topics of interest: HIV, 
STIs, and S. aureus. These topics will first be explored in the general, non-incarcerated 
population. The chapter will conclude with a discussion of how these diseases impact 
correctional settings. 
HIV/AIDS in the United States 
HIV/AIDS has had devastating effects on individuals and society at large since its 
inception in the 1980s. There were an estimated 1.2 million people living with HIV in the U.S. at 
year-end 2008 (Centers for Disease Control and Prevention, 2011b). Even more alarming is the 
fact that 20% of these cases were undiagnosed. Undiagnosed estimates are derived using a back-
calculation approach based on the number of HIV diagnoses in a calendar year and HIV disease 
severity of individuals within the calendar year of diagnosis (Hall, et al., 2008).   The most recent 
data available report an incidence of 56,300 HIV cases in 2006 (Hall, et al., 2008). At year-end 
2008, there were an estimated 479,868 children and adults living with AIDS and 594,496 
persons had died of AIDS in the U.S, since these data have been collected (Centers for Disease 
Control and Prevention, 2011a).  In recent years, HIV/AIDS has affected certain demographics 
disproportionately, further exacerbating their propensity to poor health outcomes. Although 
African-Americans comprise only 12% of the total U.S. population, they accounted for 48% of 
persons living with HIV/AIDS in 2007 (Centers for Disease Control and Prevention, 2009b).  
 While HIV/AIDS remains an incurable disease, the advent of highly active antiretroviral 
therapy (HAART) in the mid-late 1990s has markedly reduced morbidity and mortality related to 




condition (Cambiano, et al., 2010; Hammer, et al., 2008). Strict adherence to complex HAART 
regimens is necessary to realize the benefits of therapy, including viral load suppression 
(Mannheimer, et al., 2002), increased CD4 counts (Wood, et al., 2004), and reduced risk of drug 
resistance (Hammer, et al., 2008). This change in disease treatment and trajectory has resulted in 
new challenges related to suboptimal medication adherence, which can result in increased risk of 
transmission of resistant strains, thereby limiting treatment options (Este & Cihlar, 2010). 
Nevertheless, despite prevention education and advancements in treatment of HIV, both the 
incidence and prevalence continue to rise in certain demographics, such as African-Americans. 
As HIV-infected individuals can now expect to live significantly longer lives than those infected 
at the onset of the epidemic, these individuals are more susceptible to contracting other 
debilitating infectious and chronic diseases.   
Sexually Transmitted Infections in the United States 
 According to the Centers for Disease Control and Prevention (2009d), there are 
approximately 19 million new cases of STIs in the U.S. annually. Common STIs include 
syphilis, gonorrhea, chlamydia, and genital herpes, in addition to HIV. Of these infections, 
syphilis, gonorrhea, and chlamydia are categorized as notifiable diseases with federally-funded 
control programs. However, because most infected individuals are asymptomatic, they are never 
diagnosed and remain untreated. The consequences of non-treatment can be severe and include 
ectopic pregnancy and infertility in women and sterility in men, although this is less common. 
Adolescents and females are at greatest risk for contracting STIs due to their physical anatomy 
which makes them more susceptible to the microorganisms responsible for STIs (Centers for 




Chlamydia is the most frequently reported STI in the U.S. with over 1.2 million cases 
reported in 2008. The infection is caused by the bacterium Chlamydia trachomatis and can be 
transmitted via vaginal, anal, or oral sex or from mother to infant during childbirth (Centers for 
Disease Control and Prevention, 2010a). Chlamydia rates for women have increased 
substantially in the past decade. In 2000, the rate of chlamydia infection among New York State 
women was 273.6 per 100,000 and increased to 616.7 per 100,000 by 2008. Rates of chlamydia 
infection in New York State remained below national levels until 2007 when they outpaced the 
national rates (Centers for Disease Control and Prevention, 2010b).  
Gonorrhea is also a bacterial infection caused by Neisseria gonorrhoeae. Despite the fact 
that gonorrhea is a notifiable disease, the CDC estimates that only half of the cases are actually 
reported, primarily due to infected individuals not seeking medical care. In 2006, there were 
358,366 cases of reported gonorrhea in the U.S. corresponding to a rate of 120.9 per 100,000 
persons. (Centers for Disease Control and Prevention, 2008)  
Unlike chlamydia and gonorrhea, genital herpes is a viral infection caused by the Herpes 
simplex virus type 2 (HSV-2). The disease is characterized by intermittent outbreaks of blisters 
in the genital area that break, leaving tender sores that may take several weeks to heal. The HSV-
2 virus can be spread by sexual contact with an infected individual even if the person does not 
have an active outbreak. Approximately 16% of people ages 14 to 49 years in the U.S. are 
infected with HSV-2. Infection rates differ between men and women at 11% and 20%, 
respectively.  Because genital herpes is caused by a virus, there is no curative pharmacological 
therapy; however, antiviral medications are available to shorten the disease course and prevent 




There are many similarities in symptomatology and complications among the common 
STIs. Most infected individuals are asymptomatic or exhibit only mild, non-descript symptoms, 
such as vaginal discharge. Because most are asymptomatic, routine screening of sexually active 
persons for STIs is the most effective means to identify and provide timely treatment for these 
infections. Pelvic inflammatory disease is the most common complication of untreated STIs in 
women and can result in infertility. Moreover, the presence of an STI makes individuals more 
susceptible to HIV infection if exposed and also increases the ability of HIV-infected individual 
to transmit the disease (Fleming & Wasserheit, 1999). Table 2.1 provides a summary of 
prevalence rates of select STIs in the U.S.  
Table 2.1 
 
Estimated Rates of Chlamydia, Gonorrhea, and Syphilis in the U.S and Correctional Facilities, 
2008  
 
Disease Men (%) Women (%) 
U.S.a Corrections U.S.a Corrections 
Chlamydia 0.21 7b 0.58 8.5b
Gonorrhea 0.10 1.4b 0.12 2.6b
Syphilis 0.02 2.3c 0.008 7.5c
a Source: CDC (2009c). Sexually Transmitted Disease Morbidity 1984 - 2008 by Gender.  
b Source: CDC (2009d). Sexually Transmitted Diseases Surveillance, 2008. 
c Source: Kahn, et al., (2006). Overview of sexually transmitted diseases. In M. Puisis (Ed.), Clinical practice in correctional 
medicine (2nd ed., pp. 175-181). Philadelphia: Mosby Elsevier. 
 
MRSA in the United States 
 Healthcare-associated MRSA (HA-MRSA). MRSA has been endemic in U.S. hospitals 
for several decades. The first cases of MRSA in hospitals were reported in the 1960s (Barrett, et 
al., 1968). Clinically, MRSA presents several treatment challenges including resistance to all 




lengths of time in colonized persons (Chambers & DeLeo, 2009). Common sites of MRSA 
infection in healthcare settings include the blood, respiratory tract, and urinary tract (Klevens, 
Morrison, et al., 2007).  
 HA-MRSA infections are associated with significant morbidity and mortality as they 
affect the most vulnerable patients who are already battling a host of other acute and chronic 
ailments. There are an estimated 126,000 hospitalizations attributed to MRSA annually 
(Kuehnert, et al., 2005) and a survey of over 1200 U.S. hospitals found an overall MRSA 
prevalence rate of 46.3 per 1000 inpatients (Jarvis, et al., 2007). In addition to the human costs, 
fiscal costs associated with MRSA have been substantial, estimated at $3.2 to $4.2 million 
annually primarily due to the prolonged hospitalization required as a result of the infection (U.S. 
Outcomes Research Group, 2005). Cosgrove and colleagues (2005) examined differences in 
mortality, length of stay, and hospital charges between patients with MRSA and MSSA 
bloodstream infections. They reported a median attributable length of stay of 2 days and a 
median attributable hospital charge of $6,916 in the MRSA patients, both of which were 
significantly higher than MSSA.  
 Community-associated MRSA (CA-MRSA).   MRSA was associated exclusively 
with hospital and long-term care facilities for many years until the emergence of MRSA 
infection among healthy community-dwelling individuals. The first cases of CA-MRSA in the 
U.S. have been traced back to the early 1990s among children with no traditional risk factors for 
MRSA in Chicago (Herold, et al., 1998). Since then, outbreaks have been reported in such 
diverse populations as athletes (Begier, et al., 2004; Centers for Disease Control and Prevention, 




2006), children attending daycares (Adcock et al., 1998), and prisoners (Aiello, et al., 2006; 
Centers for Disease Control and Prevention, 2003a, 2003c).  
 Colonization with MRSA is increasingly problematic in the community. Data collected 
from a nationally representative sample of non-institutionalized persons (n = 9,622) for the 
National Health and Nutrition Examination Survey (NHANES) from 2001-2002 estimated a 
0.8% prevalence (2.3 million persons) of nasal MRSA colonization (Kuehnert, et al., 2006). The 
prevalence of nasal MRSA colonization increased significantly to 1.5% in the subsequent years 
2003-2004 according to the NHANES sample (n = 9,004) for those years (Gorwtiz, et al., 2008). 
Genotypes typically associated with CA-MRSA strains accounted for the majority of the strains 
isolated. From 2001-2004, colonization with specific CA-MRSA genotypes increased from 7% 
to 24.2% as would be expected with the rise in MRSA colonization in the community setting 
(Tenover, et al., 2008).  
MRSA preferentially colonizes the anterior nares (Cenizal, et al., 2008), although 
colonization also occurs in other body sites, including the skin, throat, vagina, and 
gastrointestinal tract (Boyce, et al., 2005; Eveillard, et al., 2006; Nilsson & Ripa, 2006). 
Colonization with MRSA is often a prerequisite to infection, although most colonized 
individuals do not progress to infection (Miller, et al., 2003). 
 Rates of MRSA clinical infections have also risen significantly in recent years. A study 
of military medical facilities estimated an incidence of 154.7 CA-MRSA infections per 100,000 
persons in 2004 (Crum, et al., 2006). Results further suggested that many of the MRSA 
infections identified resulted from intrafamilial spread, reinforcing the significant role of close 
contact in the transmission of MRSA.  Treatment recommendations for CA-MRSA infections 




drainage, without adjunct antimicrobial therapy, is recommended as first-line therapy for 
cutaneous abscesses depending on the number and size of lesions and the presence of other 
medical co-morbidities (Lee, et al., 2004).  
 Comparison of HA- and CA- MRSA. Community-associated MRSA is 
distinguished from HA-MRSA both epidemiologically and microbiologically. Individuals 
infected with CA-MRSA lack the traditional risk factors associated with HA-MRSA, e.g., long-
term antibiotic use, recent hospitalization or surgery, residence in a long-term care facility, 
dialysis, and indwelling percutaneous medical devices and catheters (Brumfitt & Hamilton-
Miller, 1989; Lowy, 1998). Community-associated MRSA is more likely to manifest as a skin 
and soft tissue infection (SSTI), whereas HA-MRSA tends to infect sites such as the blood, 
lungs, and urinary tract (Naimi, et al., 2003). 
 Healthcare-associated and community-acquired MRSA exhibit distinct genotypes, with 
the USA-100 and USA-200 clones more often isolated in HA-MRSA samples (McDougal, et al., 
2003) and the USA-300  and USA-400 clones most often associated with CA-MRSA (Diep, et 
al., 2008; Tenover, et al., 2006). Although the USA-300 clone was first isolated from CA-MRSA 
samples and still predominates in community-dwelling individuals, researchers have found that 
this clone is infiltrating healthcare facilities and becoming a cause of HA-MRSA infections 
(Gonzalez, et al., 2006; Liu, et al., 2008; Maree, et al., 2007; Popovich, et al., 2008; Seybold, et 
al., 2006; Skov & Jensen, 2009).   
 Antibiotic susceptibility profiles also vary, with CA-MRSA strains exhibiting 
susceptibility to a wider range of antibiotics than HA-MRSA (Chambers & DeLeo, 2009; Naimi, 
et al., 2003). Results from a study examining differences between CA- and HA-MRSA in 




clindamycin, erythromycin, and gentamicin compared to HA-MRSA strains. More than 90% of 
both CA-MRSA and HA-MRSA strains were susceptible to rifampin, tetracycline, vancomycin, 
and trimethoprim/sulfamethoxazole (TMP/SMZ) (Naimi, et al., 2003). In HIV-infected persons 
with MRSA, antibiotic therapy has been shown to be further complicated by resistance to many 
of the drugs commonly prescribed for non-HIV-infected persons with MRSA (Krucke, et al., 
2009). Over 90% of MRSA cultured from abscesses were resistant to cefazolin and 
erythromycin; 54.8% were resistant to ciprofloxacin and 35.4% were resistant to clindamycin. 
No resistance to rifampin, vancomycin, or TMP/SMZ was identified, although vancomycin 
resistant strains have been reported (Tenover, et al., 2001).  
HIV and MRSA: Risk Factors for Co-Infection  
 The literature suggests that HIV-infected individuals are colonized and infected with 
MRSA at higher rates than the general population. Cenizal and colleagues (2008) estimated a 
10% prevalence of MRSA among HIV-infected ambulatory patients, representing an exponential 
increase compared to the general population prevalence of 1.5% (Gorwitz, et al., 2008). 
Similarly, Hidron et al (2005) found that HIV-infected persons entering an urban hospital were 
significantly more likely to be colonized with MRSA compared to HIV-negative persons (17% 
vs. 6%; OR = 3.2; p < 0.001). 
Research identifying the microbiological link between CA-MRSA and HIV has been 
limited to date and primarily retrospective in nature. Several factors, including 
immunodeficiency, high-risk sexual behaviors, injection drug use (IDU), and widespread use of 
antibiotics, have been hypothesized to contribute to the increased rates of CA-MRSA infection 




2005). However, to date, there has been no consensus as to the underlying factors contributing to 
the increased rates of CA-MRSA in the HIV population.  
Immunosuppression, the hallmark of HIV disease, has been hypothesized to contribute to 
the increased rates of MRSA among HIV-infected persons. However, conflicting data exist in the 
literature regarding if and how the degree of immunosuppression in HIV-infected individuals 
contributes to subsequent MRSA infection. Crum-Cianflone et al (2009) identified a significant 
risk for MRSA infection in an HIV-infected sample with lower CD4 counts, a finding that has 
been supported by others in the literature (Cenizal, et al., 2008; Mathews, et al., 2005; Ramsetty, 
et al., 2010).  However, Trinh et al (2009) found that advanced HIV status, as evidenced by CD4 
count <50 cells/mm3, was not associated with MRSA infection in a small HIV-infected sample 
(n = 43). Moreover, a study by Shet et al (2009) revealed significantly higher rates of MRSA 
colonization and infection among non-immunosuppressed HIV-infected patients when compared 
to those not infected with HIV, suggesting that the presence of HIV, regardless of its stage, is a 
significant risk factor for contracting MRSA. Given the improvement in immune status 
associated with strict adherence to HAART, some researchers suggest that better management of 
HIV may mitigate the  risk of MRSA infection in this population (Ramsetty, et al., 2010; Crum-
Cianflone, et al., 2009) although empirical data to support this claim are lacking. 
High-risk sexual behavior has also been implicated in the increased rates of co-infection 
with MRSA observed among HIV-infected persons. Several studies have suggested that MSM 
have significantly elevated risks of contracting MRSA (Lee et al, 2005; Mathews et al, 2005; 
Diep et al, 2008).  High-risk sexual behavior, including having multiple sex partners and 
inconsistent condom use, was associated with increased risk of CA-MRSA SSTI in a sample of 




revealed incidences of USA-300 MRSA infection to be 26 and 170 cases per 100,000 in the San 
Francisco general population and MSM, respectively. Interestingly, although both HIV infection 
and being a MSM were risk factors for multidrug-resistant USA300 infection, the influence of 
being an MSM persisted as an independent predictor of HIV status. This independent influence 
of being an MSM led the authors to hypothesize that the potential skin trauma associated with 
sexual activity in this population may exert the greatest influence in contracting MRSA. 
Injection drug use is prevalent among HIV-infected individuals who also carry MRSA. 
Mathews et al (2005) reported that 23% of their HIV-MRSA co-infected sample had a history of 
IDU. Men who have sex with men and injection drug users were more likely to be infected with 
CA-MRSA compared to individuals with neither risk factor (adjusted hazard ratio = 5.0; p = 
0.008), although the individual influence of IDU was not reported. The sharing of dirty syringes 
among injection drug users may be the primary mechanism whereby MRSA is transmitted 
between HIV-infected individuals in this particular population.   
Researchers have also reported conflicting data regarding the role of antibiotic use in 
MRSA among HIV-infected persons.  The Centers for Disease Control and Prevention (2009a) 
recommend the use of TMP/SMZ to prevent opportunistic infections, namely pneumocystis 
pneumonia, in HIV-infected persons. Lee et al (2005) found that use of TMP/SMZ was 
protective against CA-MRSA SSTI among HIV-infected MSM. Additionally, Cenizal et al 
(2008) demonstrated that current use of TMP/SMZ was protective for MRSA colonization 
among a sample of HIV-infected ambulatory patients. Similarly, Trinh et al (2009) found current 
or recent use of antibiotics to be associated with a low rate of MRSA colonization in an HIV-
infected sample. These findings are contrary to results reported in the general population, in 




However, they are consistent with the supposition that prophylactic antibiotic use reduces the 
risk of developing opportunistic infections in this population. Nevertheless, other studies have 
revealed increased risk of MRSA colonization and infection among HIV-infected individuals 
who received antibiotics prior to MRSA infection (Shet, et al., 2009; Skiest, et al., 2006). Crum-
Cianflone and colleagues (2007) found recent use of beta-lactam antibiotics to be predictive of 
CA-MRSA in their HIV-infected sample. A study of ambulatory HIV clinic patients identified 
treatment with clindamycin in the previous 12 months as an independent risk factor for MRSA 
USA-300 infection (Diep, et al., 2008).  
Infections in United States Prisons 
 There are an estimated 2.3 million persons incarcerated in U.S. jails and prisons, more 
than in any other country (U.S. Department of Justice, 2010a).  Moreover, rates of certain health 
conditions, including HIV/AIDS, substance abuse, and mental illness have been found to be 
considerably higher in prison than the general population (Feliner & Abramsky, 2003; Hammett, 
et al., 2001; Pollack, et al., 1999). Research suggests that many high-risk behaviors in which 
inmates engage prior to incarceration, including unprotected sex and IDU, persist in correctional 
facilities (Hammett, 2006). Despite the fact that sexual contact is prohibited in jails and prisons, 
a survey of inmates in one state estimated that up to 44% of inmates have sexual contact with 
other inmates (Krebs, 2002). The risk of contracting infectious diseases may be further amplified 
due to the absence of preventive mechanisms such as condoms and clean needles (Mahon, 1996; 
Swartz, et al., 2004).       
 HIV. Prisons and jails house a significant proportion of the HIV-infected population in 
the U.S. It was recently estimated that approximately 17% of all HIV-infected persons and 12% 




(Spaulding, et al., 2009). Consequently, U.S. prisons and jails report substantially higher 
proportions of HIV-infected persons compared to the general population. The U.S. Department 
of Justice (2009) reported that at year-end 2008, 1.5% of state and federal prisoners were 
infected with HIV compared to 0.47% in the civilian population. In New York, the total number 
of HIV-infected prisoners decreased from 2007 to 2008; nevertheless, the state reported the 
largest percent of HIV-infected prisoners at 5.8%. Moreover, the rate of AIDS among prisoners 
(0.41%) is more than double the rate in the general population (0.17%).  
 Sexually transmitted infections. Sexually transmitted infections represent a significant 
burden of disease in correctional facilities. A recent review of the literature conducted by 
Hammett (2009) highlighted the disproportionate burden of STIs within U.S. prisons and jails. 
Table 2.1 provides a summary of selected STI prevalence rates in correctional facilities discussed 
in that review. 
 Individuals entering jails and prisons account for a substantial proportion of the overall 
reported cases of several STIs. Upon discontinuation of routine STI screening at a male Chicago 
jail, the number of reported cases of chlamydia and gonorrhea among men in the city decreased 
from 40.6% to 5.1% and 16.3% to 1.9%, respectively (Broad, et al., 2009). These data 
underscore the fact that universal screening for STIs in jails captures a significant proportion of 
infected persons that may otherwise remain undiagnosed. Many of the individuals entering these 
facilities have their first interaction with primary health care as a result of being incarcerated. 
Consequently, incarceration provides an opportunity for medical screening and intervention in an 
otherwise hard to reach population. Mandatory and voluntary screening programs for common 
STIs, such as chlamydia and gonorrhea, in correctional facilities identify many cases of 




MRSA. While outbreaks of MRSA in prisons have been reported across the 
country in Georgia, California, and Texas (Centers for Disease Control and Prevention, 2003a), 
there is evidence to suggest that MRSA may be endemic in prison populations (Lowy, et al., 
2007). Lowy and colleagues (2007) studied S. aureus colonization and infection in New York 
State prisons. Among isolates of clinical infection and colonization, 48.3% (29/60) and 10.5% 
(13/124) of the S. aureus positive samples were MRSA positive, respectively (p < 0.001).  
 The restrictive nature of prisons limits inmate and staff access to many basic infection-
prevention supplies, including certain bath soaps, alcohol-based hand sanitizer, and clean laundry 
(Aiello, et al., 2006; Bick, 2007).  Prisons frequently operate above capacity and lack the 
facilities to isolate infected individuals or consistently provide personal protective equipment for 
staff. Furthermore, the often abrupt transfer and discharge of inmates has been suggested as a 
barrier to effective diagnosis and treatment of infections, including MRSA (Bick, 2007).  
Risk factors for MRSA infection identified during outbreaks in correctional facilities are 
primarily associated with poor hygiene and inadequate infection-control practices. An 
investigation of a 2001 MRSA outbreak in a Georgia detention center identified prolonged 
incarceration (>36 days) and outdoor work duty as independent risk factors for MRSA infection. 
A second investigation during 2002 at a Georgia prison identified previous antimicrobial use, 
self-draining of boils, skin laceration, washing clothes by hand, sharing soap, and arrival at the 
prison after 2001 as risk factors for MRSA infection. In 2001, the Los Angeles County jail 
system observed inadequate infection-control measures in the clinic area after an outbreak of 
MRSA was identified from a series of suspected spider bites. Finally, in 2001 the Texas 
Department of Criminal Justice identified previous skin infections and recent close contact with 




facility. Following each of these outbreaks, administrators in these facilities implemented new 
guidelines targeted at improving infection control practices of both inmates and staff. Measures 
taken within the various facilities included routine surveillance for skin lesions, culturing of all 
draining skin lesions, standardized wound treatment recommendations with non- beta-lactam 
antimicrobials, hygiene education for inmates, and more frequent laundry changes for inmates. 
Implementation of these guidelines led to varying levels of success from non-significant 
decreases in the incidence of MRSA to near eradication of MRSA infections in these facilities 
(Centers for Disease Control and Prevention, 2003a; Wootton, et al., 2004). 
Summary 
 The burden of MRSA on HIV-infected persons in the community has been studied. 
Research has revealed elevated rates of MRSA among HIV-infected persons and several risk 
factors for these elevated rates have been suggested, including high-risk sexual behavior. While 
the impact of MRSA on HIV-infected persons has been examined in the community, the burden 
of neither MRSA nor MSSA on HIV-infected prisoners has been documented. Many of the risk 
factors identified in the community converge in the prison setting, increasing the likelihood of 
co-infection. However, neither the HIV- nor broader STI-infected populations have been studied 





Chapter 3: Methodology 
Specific Aims 
Using a sample of inmates at two New York State prisons, the specific study aims were 
to:  
1. Describe the patterns of S. aureus (MSSA and MRSA) co-infection with HIV or 
STIs 
2. Identify risk factors for S. aureus (MSSA and MRSA) co-infection with HIV or 
STIs 
Study subjects were a convenience sample comprised of a subset of inmates who 
participated in a larger study of S. aureus transmission in New York State prisons as described 
below. 
Research Design 
The study was a secondary analysis of data from a larger cross-sectional study described 
below, using descriptive and correlational analyses.  
Parent Study  
This study was part of a larger study (Risk Factors for Spread of Staphylococcus aureus 
in Prisons, National Institutes of Health, National Institute of Allergy and Infectious Diseases 
#1R01AI082536-01A1; Lowy and Larson, Principal Investigators) to develop a comprehensive 
understanding of the risk factors and transmission dynamics of S. aureus in New York State 
prisons. Specific aims of the larger study are to: 1) identify patterns of S. aureus strain 
transmission within the prison; 2) determine the factors associated with the development of 
clinical S. aureus infections within the prison and; 3) identify risk factors associated with 




anticipate the information gained from their study will be used to design interventions to reduce 
the risk of S. aureus infection within the prison population. All data were collected and managed 
by two trained research assistants (RAs) and a study coordinator employed by the parent study. 
One RA was a female with a baccalaureate in biology and the other RA was a male with 
baccalaureate degrees in special education and social psychology. Both RAs had previous 
experience interviewing vulnerable populations.  
Setting and Sample 
The overall study population for the dissertation was dictated by the parent study. 
Participants were recruited from two New York State prisons: Sing Sing Correctional Facility 
(Sing Sing) and Bedford Hills Correctional Facility (Bedford Hills). Sing Sing is a maximum 
security facility which houses approximately 1731 male prisoners. Approximately 30-50 inmates 
are admitted to the facility weekly and 59 are released monthly. The average length of 
incarceration is 21 months. Inmates from  
Bedford Hills is the only maximum security female facility in the state and houses 
approximately 745 prisoners. This facility serves as a reception center for female inmates who 
are awaiting transfer to other correctional facilities where they will carry out their sentences or 
who have been sentenced to a maximum security facility. Approximately 20-30 inmates are 
admitted to the facility weekly and 29 are released monthly. The average length of incarceration 
is 38 months. The majority of prisoners in both facilities are African-American and convicted for 
violent or drug-related crimes. Table 3.1 provides a summary of the demographic characteristics 








Table 3.1  




Sing Sing Bedford Hills 
Number of inmates 1731 745 
Number of new inmates/week 30-50 20-30 
Number of inmates released/month 59 29 
Ethnic status (%) 
   African-American 
   Hispanic 










   16-20 
   21-29 
   30-39 
   40-49 
   50-59 















Average length of incarceration (months) 21 38 
Prior arrest record (%) 
   No prior arrest 
   No prior conviction 
   Prior conviction 











Crime group (%) 
   Violent felony 







Note: Data current as of March 2011 
Recruitment 
 Eligibility criteria to be included in the study were: inmate at Bedford Hills or Sing Sing 
prison with the ability to provide informed consent; at least 16 years of age; a sentence of at least 
one-year; new prisoner undergoing the initial intake process. Prisoners on death row and in 
isolation facilities were excluded due to security reasons and because they have minimal contact 
with other prisoners.  
 The RAs visited each facility for 4-6 hours/day for two days each week. Potential 
participants were approached by the RAs during the prisoner intake process. During the intake 




medical screening. Inmates at Sing Sing were approached in the State Shop, the facility’s general 
processing center. Each facility provided the RAs with a list of individuals currently being 
processed for intake. The RAs then invited each individual prisoner into a private room where an 
informational pamphlet providing an overview of MRSA and describing the study was given. 
The RAs then explained the study, with its associated risks and benefits, to prisoners expressing 
interest. The RAs answered any questions the prisoners had and written informed consent was 
obtained from all who agreed to participate.  
Data Collection Procedures 
 Data were collected from November 2009 to January 2011 via interviews, medical record 
review, and biological cultures. Study interviews took place in individual exam rooms during 
inmates’ initial processing into each facility. Correction officers accompanied prisoners to the 
interview, but were not present in the interviewing room to maintain participant confidentiality.  
 After the prisoner agreed to participate and provided informed consent, s/he was assigned 
a unique study number that was associated with all study-related forms and biological cultures 
obtained. Research assistants obtained separate cultures from each participant’s anterior nares, 
oropharynx, and any other visible or participant-reported site of infection or open wound. 
Cultures were obtained by gently rotating a pre-moistened culturette in both anterior nares or the 
posterior pharynx and then placing the swab in transport media. Each culture was labeled with 
the participant’s study number and site of culture. The RAs then conducted a structured 
interview using a standardized interview questionnaire. Additionally, the RAs obtained data from 
the participant’s Department of Correctional Services (DOCS) medical records using an 




 All women at Bedford Hills are tested for syphilis, gonorrhea, chlamydia, and given PAP 
smears at intake. All men at Sing Sing are tested for syphilis at intake. Inmates at both facilities 
are offered voluntary HIV testing. Results from these tests are available in the medical record. 
Microbiological and Molecular Epidemiological Techniques   
Microbiological culturing was performed in the laboratory of the principal investigator of 
the parent study (Lowy) at Columbia University Medical Center. Each swab was incubated in 
6% NaCl supplemented Tryptic Soy Broth (Becton Dickinson) at 35˚C overnight in order to 
enrich S. aureus selection before being plated onto Mannitol Salt agar (Becton Dickinson) and 
incubated at 37˚C for 48 hours. Individual positive colonies were then streaked onto sheep blood 
agar (5% on trypticase soy agar) before being confirmed as S. aureus with the latex coagulase 
test Staphaurex (Remel, KS) (Lowy, et al., 2007). Positive samples were spa-typed and 
compared using the Ridom Staph Type software (Ridom GmbH, Wuerzburg, Germany) 
(Harmsen, et al., 2003; Koreen, et al., 2004). Positive methicillin-resistant isolates were 
Staphylococcal Chromosomal Cassette (SCC) mec typed as previously described (Boye, Bartels, 
Andersen, Moller, & Westh, 2007; International Working Group on the Classification of 
Staphylococcal Cassette Chromosome Elements, 2009; Oliveira & de Lencastre, 2002). 
Parameters for the Based Upon Repeat Pattern (BURP) clustering within the Ridom StaphType 
software using standards determined elsewhere (Mellmann, et al., 2008; Weniger, et al. 2006) 
were used to further characterize the isolates. Positive samples were also examined by pulsed 
field gel electrophoresis (PFGE) via SmaI digest (Hallin, et al., 2007). 
Consideration of Human Subjects 
The parent study was approved by the Institutional Review Board (IRB) of Columbia 




New York State DOCS. A certificate of confidentiality was obtained from National Institutes of 
Health to protect identifiable research information from forced disclosure. The student 
investigator was added as personnel to the IRB protocol for the larger study and became an 
integral part of the study team, attending weekly team meetings and actively participating in the 
development and testing of data collection instruments, methods, and the database.  
Study Variables and Instruments 
Variables. Demographic data collected included age, race/ethnicity, gender, highest 
level of education, recent residence, and history of injection drug use. Additional information 
regarding medical history was obtained, including HIV status, history of STIs, history of skin 
conditions, and antibiotic use among others. The primary outcome variables were STI-S. aureus 
and HIV-S. aureus co-infection. Colonization with S. aureus (MSSA and/or MRSA) in either the 



























Study Variables, Source of Data, and Levels of Data 
 




Interview Years Years Continuous 







y, n, dk, ref, 
other 
Categorical 
Sex Interview Site of recruitment BH = female; 
SS = male 
 
Categorical 
Educationb Interview Highest  level of 
education completed 
< HS; HS/ 
GED; some 
college; 
college grad;  
 
Categorical 









Chronic diseased Interview Presence of diabetes, 
cancer, cardiovascular, 
pulmonary, kidney, 
liver, or other disease 
 
y, n, dk, ref Categorical 
HIV status Interview, 
Chart 






Chart Herpes; syphilis; 
gonorrhea; chlamydia; 
HPV; other 
y, n Categorical 
Sexual activity Interview Sexually active in 
previous six months 
 
y, n Categorical 
Sexual partnerse Interview Number of male and 
female partners in 
previous six months 
 
Numeric Continuous 







Table 3.2 cont’d 
 
Variable Data Source Operationalization Measurement Level of 
Data 
     
Personal item use Interview Share any personal 
items 
y, n, dk, ref Categorical 
Shaving Interview  Shave any body part 
 
y, n, dk, ref Categorical  
Chronic skin 
conditionsd  
Interview  Psoriasis; eczema;  
acne; other 
 
y, n, dk, ref Categorical 
S. aureus historyd Interview Previous S. aureus 
infection 
 
y, n, dk, ref Categorical 
Antibiotic used Interview Antibiotic use in 
previous six months 
 
y, n, dk, ref Categorical 
Injection drug use Interview Current or past use 
 
y, n, dk, ref Categorical 
S. aureus colonization Nasal and 
oropharyngeal 
culture 
Positive culture y, n Categorical 
Note: y= yes; n=no; dk=don’t know; ref= refused; BH = Bedford Hills; SS = Sing Sing; HS = high school; GED = general 
educational development; All categorical data was dummy coded as 0 (absence) or 1 (presence) of condition unless otherwise 
noted. 
a Responses dichotomized to Black, non-Black 
b Responses dichotomized to less than high school, high school graduate or more 
c Responses dichotomized to fair/poor, excellent/good 
d A response of ‘don’t know’ was coded as ‘no’ 
e Responses used to create  new variable reflecting multiple sex partners(i.e., response of  >1) and men who have sex with men 
(i.e., male subject who responded as ≥1 male partner) 
 
Interview questionnaire. The questionnaire was initially developed from previous 
community-based surveys of MRSA colonization and from preliminary interviews obtained 
during a prevalence survey of MRSA colonization in prisoners (Lowy, et. al., 2007). It was 
further pilot tested from November to December 2009 using the first 17 interviews at Sing Sing 
and the first 35 interviews at Bedford Hills. The final questionnaire contained 51 items in the 
following 14 categories: demographics, education, housing history, occupation during 
incarceration, exercise during incarceration, hygiene during incarceration, chronic or ongoing 




tattoos and piercings, sexual relationships, substance use, group activities during incarceration, 
and history of fighting. Participants were asked to recall responses to items anytime in the past 
and/or within the previous six months. The questionnaire was administered by the interviewer 
reading each question to the participants and recording their responses. The interview took an 
average of 15 minutes to complete.  
 Medical record extraction form.  The medical record data extraction form was 
developed from an extensive literature review for two purposes: (a) as a reliability check for 
available data which were also self-reported by inmates, and (b) to obtain additional health-
related information of relevance to potential S. aureus, STI, and/or HIV infection. Data were 
extracted from the DOCS medical record for each participant, including the problem list, medical 
screening reception form, immunization form, medical history, treatment and medication 
records, health provider order sheet, and physical examination form.  
 The form was also pilot tested from November to December 2009 using the first 17 chart 
reviews at Sing Sing and the first 35 chart reviews at Bedford Hills. It was modified to better 
reflect the information available in the medical records and the sequence of the questions were 
arranged to be consistent with the organization of the medical records, both of which facilitate an 
efficient and accurate process of data extraction. The final form contained 33 items in the 
following 10 categories: chronic or ongoing medical condition(s) or infections, skin conditions, 
venereal diseases, dental problems, tattoos and needle marks, antibiotic use, skin problems and 
Staphylococcus infections, bodily injuries, substance use, and sexual activity. Both study 







Participants’ consent, interview, and medical record extraction forms were kept in locked 
files in a locked office allocated for the study. All data were entered into an encrypted database 
designed for the study. Each member of the study team had a unique username and password to 
access the database. Participant names were not entered into the database. Upon completion of 
the parent study, all documents containing personal identifying information will be destroyed. 
Power Analysis 
 An a priori power analysis was performed under the following assumptions: 1) 
prevalence rates for S. aureus, HIV, and STIs of 25%, 6%, and 10%, respectively; 2) a detectable 
odds ratio of 2-3; 3) a Chi-square two-sided test of significance with α = .05. The prevalence 
rates used are based on the review of the literature for S. aureus , HIV, and STIs. The target total 
enrollment for the larger study was 910. Given this fixed sample size, the calculated power to 
detect an odds ratio of 3 for MRSA-HIV and MRSA-STI co-infection is 0.8 and 0.9, 
respectively. Table 3.3 summarizes the calculations performed. The study was notably 
underpowered to detect an odds ratio of 2 or less, given the target enrollment for the larger study.  
Table 3.3 
A Priori Power Analysis Calculations 
ntotal sample nhiv nsti Detectable OR Powerhiv Powersti
910a 55 91 2 0.59 0.78 
910a 55 91 3 0.96 0.99 
1411b 85 141 2 0.80 - 
946b 57 94 2 - 0.80 
Note: OR = Odds ratio; STI = sexually transmitted infection; The values calculated are for a two-sided χ2 test, α = .05, assuming 
prevalence of S. aureus, HIV, and STI of 25%, 6%, and 10%, respectively.  
a Value represents the targeted enrollment for the larger study. 
b Value represents the total sample needed to detect an OR of 2  
Data Analysis  
All data were analyzed using SPSS version 18 (Chicago, IL). Statistical significance was 




larger study’s database into an SPSS file. To maintain confidentiality, publicly available DOCS 
inmate identification numbers were not exported from the secure database. Preliminary analysis 
of the data revealed more positive responses to key risk factor questions (e.g., drug use and 
sexual activity) during the interview when compared to the medical record review; therefore, 
only responses from the interview were used for these variables.  Because the interview did not 
include questions about STIs, information pertaining to STIs, including culture data for the 
women, was obtained from the medical record review.  
The parent study utilizes two independent samples (men at Sing Sing and women at 
Bedford Hills), which differ in several ways aside from the differences in gender. Inmates from 
Sing Sing are almost exclusively transferred from other prisons, whereas inmates from Bedford 
Hills tend to be transferred from jails. The difference in most recent prior residence is 
noteworthy given variations in facility operation, layout, and inmate length of stay between 
prisons and jails. In general, the jail population is more transient than the prison, with greater, 
faster turnover and jails tend to be more overcrowded. Consequently, data from the two prisons 
were not combined for analysis as the differences between the facilities could potentially be 
related to S. aureus transmission and obscure comparisons.   
Demographics.  Descriptive statistics, including frequencies, percentages, mean, 
and standard deviation, were used to describe the demographic characteristics of the sample.  
Categorical variables were dummy coded as not present (0) versus present (1) to facilitate 
interpretation of study results. To determine statistically significant differences between selected 
groups e.g., by gender, HIV, and STI status, for categorical variables, chi-square tests were 
performed for those variables with individual cell values of at least five and Fisher’s exact tests 




and range for continuous variables were calculated and two-sided, independent sample t-tests 
were used to determine statistically significant differences between selected groups. Levene’s 
test was used to assess equality of variances between groups. Chi-square and t-tests were used 
for categorical and continuous data, respectively to compare age and education of the sample to 
the overall population of each facility and to the overall New York State prison population. 
Neither facility- nor state-level aggregate data were available for other demographic and inmate 
history data. 
Specific Aim One.  The first study aim was to describe the pattern of S. aureus 
(MSSA and MRSA) co-infection with HIV or STIs. Frequencies and percentages were used to 
determine the individual prevalence of HIV, STIs, and S. aureus in the study population. New 
variables were then created to identify subjects co-infected with HIV-S. aureus and STI-S. 
aureus. Chi-square or Fisher’s exact tests were computed to examine differences in S. aureus 
rates between HIV-infected individuals and those uninfected as well as those with and without 
STIs in each prison independently.  
Specific Aim Two. The second study aim was to identify risk factors for S. aureus 
(MSSA and MRSA) co-infection with HIV and/or STIs. A small sample of HIV-infected 
subjects (n = 27) and even fewer subjects co-infected with S. aureus (n = 15) prohibited the 
fitting of a regression model to determine risk factors for HIV-S. aureus co-infection. 
Consequently, only a descriptive report of HIV-S. aureus co-infection was possible. Similarly, 
the small sample of men co-infected with STI-S. aureus (n = 16) prevented the fitting of a 
regression model to determine risk factors for STI-S. aureus co-infection in this group. 
Therefore, a model to identify risk factors for STI-S aureus co-infection was only fit for women. 




describing risk factors for S. aureus colonization. Chi-square, Fisher’s exact, and t-tests were 
used as appropriate in univariate analyses to assist in determining possible risk factors to enter 
into the multivariate model. Potential predictor variables were and entered into a binary logistic 
regression model based on theoretical plausibility.  Multicollinearity among independent 
variables was assessed using tolerance values and variance inflation factors. Tolerance values 
<0.1 and variance inflation factors   >2.5 suggested high correlation among the predictor 
variables. The model was controlled for traditional demographic variables including age, 
race/ethnicity, and education. Adjusted odds ratios with 95% confidence intervals were 
calculated for each potential predictor entered into the model. Those variables found to be 
statistically significant were included in the final model.  Statistical significance was set at α < 
0.05 to assess the probability that the independent variables in the model were not associated 





Chapter 4: Results 
Introduction  
The aim of this study was to estimate the rates of HIV-S. aureus and STI-S. aureus co-
infection and to examine risk factors for co-infection in a prison population. This chapter will 
present statistical results of the study guided by the study’s specific aims. 
Demographic Findings 
 The final sample consisted of 373 women from Bedford Hills and 383 men from Sing 
Sing. Of all inmates approached to participate in the study, 86% at Bedford Hills and 79% at 
Sing Sing agreed to be subjects for an overall participation rate of 81%. The mean age of the 
total sample was 34.4 years and was similar between subjects at the two prisons. Men prisoners 
were significantly more likely to be Black than women (p = .01). Nearly 50% of the sample had 
not completed high school, which was similar among men and women. Chronic diseases were 
prevalent in subjects in both facilities with nearly 75% of the sample reporting having one or 
more chronic illnesses, with pulmonary disease being the most frequently reported (28.7%). Men 
and women differed significantly on several variables; women were more likely to report a 
history of HIV/AIDS, STI, previous S. aureus infection, injection drug use, and having multiple 
sex partners (p < .05). Approximately 20% of the sample reported having a chronic skin 
condition, but only 4% reported having a S. aureus infection in the past. Hygiene practices also 
differed, with women reporting taking more showers per week and sharing more personal items 
while men reported more shaving. Table 4.1 summarizes demographic characteristics of the 






Demographic, Clinical, and Behavioral Characteristics of Inmates at Sing Sing and Bedford 
Hills Correctional Facilities (n=756) 
 








Mean age ± SD,  
range (years) 
34.4 ± 10.1, 
16-64 





Race/ethnicity, n (%) 
    Black 











Education level completed, n (%) 
    Less than high school 















Previous residence, n (%) 
    Jail 
    Prison 














General health, n (%) 
    Excellent or good 













Chronic disease, n (%) 
    Diabetes 
    Cardiovascular 
    Pulmonary 
    Kidney 
    Liver  
    Cancer 
    Otherd  
 
36(4.8)  
110 (14.6)  
217 (28.7) 
11 (1.5)  





49 (12.8)  
91 (23.8)  
6 (1.6)  




27 (7.2)  
61 (16.4) 
126 (33.8)  
5 (1.3)  
27 (7.2)  










HIV/AIDS, n (%) 27 (3.6) 8 (2.1) 19 (5.1) .03 
STI, n (%) 
    Syphilis 
    Gonorrhea 
    HPV 
    Chlamydia 
    Herpes 





























Chronic skin condition, n (%) 148 (19.6) 71 (18.5) 77 (20.6) .47 
Past S. aureus infection, n (%) 30 (4.0) 7 (1.8) 23 (6.2) .002 
Systemic antibiotics, n (%)e 217 (28.7) 71 (18.5) 146 (39.1) <.001 
Injection drug use, n (%) 65 (8.6) 20 (5.2) 45 (12.1) .001 
Sexually active, n (%)e 266 (35.2) 77(20.1) 189 (50.7) <.001 





Table 4.1 cont’d 
 








Men who have sex with men, n 
(%)e 
11 (1.5) 11 (2.9) -- -- 
High risk sexual activity, n (%)e,f 70 (9.3) 32 (8.4) 38 (10.2) .38 
Average showers per week,  
mean ± SD, range 
7.0 ± 4.0 
0-21 
5.1 ± 3.2 
0-21 
8.8 ± 4.0 
1-21 
<.001b 
Share personal items, n (%)g 100 (13.2) 33 (8.6) 67 (18.0) <.001 
Shave any body part, n (%) 
    Arms 
    Legs 
    Torso 
    Crotch 
    Face 
`   Underarms 
    Head   





































Note. SD = standard deviation. STI = sexually transmitted infection. HPV = human papilloma virus. S. aureus = Staphylococcus 
aureus.  
a Two-sided χ2 unless otherwise noted 
b Two-sided t-test 
c Fisher’s exact test 
d Other chronic diseases included neurologic, endocrine, musculoskeletal, optic, gastrointestinal, hematologic, and psychological 
diseases. 
e Participants were asked if they engaged in this activity in the previous six months. 
f High-risk sexual activity constituted having multiple sex partners and/or being a man who has sex with men. 
g Personal items included towels, clothes, soap, razors, combs/brushes, deodorant, and nail clippers. 
 
 Compared to the entire Sing Sing and Bedford Hills populations, this sample was 
generally younger as illustrated in Table 4.2. High school completion status was similar between 
subjects from Sing Sing and all men in New York State Department of Corrections (DOCS) (p = 
.86). This sample of women from Bedford Hills was less likely to have completed high school 














Age and High School Completion Status of a Sample from Bedford Hills and Sing Sing 
Correctional Facilities Compared to New York State Department of Corrections Population 
 
 Sing Sing 
sample 
(n = 383) 
Sing Sing 
(n = 1711) 
DOCS total 
male 




(n = 373) 
Bedford 
Hills 




(n = 2256) 
Age (years), 
n (%)a 
  16-29   
  30-49   

































217 (55.0) - 30,951b (57.0) 174 (47.0) - 1222c 
(54.0) 
Note. DOCS = Depart of Correctional Services. Totals for each facility and DOCS data current as of March 2011. 
a χ2 test comparing Sing Sing sample/total and Bedford Hills sample/total, p < .05 
b χ2 test comparing Sing Sing sample to DOCS male total for high school completion, p = .86. 
c χ2test comparing Bedford Hills sample to DOCS female total for high school completion, p = .007 
 
 The prevalence of HIV/AIDS in the sample was 3.6%. Among women, compared to non-
HIV-infected subjects, HIV-infected subjects were more likely to be Black and to have not 
graduated from high school (p < .05). Reports of injection drug use among HIV-infected male 
subjects (25%) were approximately five times those without HIV (4.8%). No significant 
differences in sexual activity history were found between HIV-infected and uninfected male 
subjects. However, female HIV-infected subjects were more likely to report a history of STI (p = 
.01). Tables 4.3 and 4.4 summarize demographic characteristics of HIV-infected male and 








Table 4.3  
Demographic, Clinical, and Behavioral Characteristics of HIV- and non-HIV-infected Inmates 
at Sing Sing Correctional Facility (n=383) 
 
Characteristic HIV  
(n = 8) 
non-HIV 
(n =  375) 
pa 
Mean age ± SD,  
range (years) 
39.0 ± 12.4, 
24-56 
33.6 ± 9.4, 
17-64 
.11b 
Race/ethnicity, n (%) 
  Black 








Education level completed, n (%) 
  Less than high school 








General health, n (%) 
  Excellent or good 










Chronic disease, n (%) 
  Diabetes 
  Cardiovascular 
  Pulmonary 
  Kidney 
  Liver  
  Cancer 

























STI, n (%) 0 35 (9.3) 1.00 
Chronic skin condition, n (%)d 2 (25.0) 69 (18.4) .65 
Past S. aureus infection, n (%) 0 7 (1.9) 1.00 
Systemic antibiotics, n (%)e 2 (25.0) 69 (18.4) .65 
Injection drug use, n (%) 2 (25.0) 18 (4.8) .06 
Sexually active, n (%)e 2 (25.0) 75 (20.0) .66 
Multiple sex partners, n (%)e 1 (12.5) 22 (5.9) .39 
Men who have sex with men, n (%) 1 (12.5) 10 (2.7) .21 
High risk sexual activity, n (%)e,f 1 (12.5) 31 (8.3) .51 
Average showers per week,  
mean ± SD, range 
6.1± 6.3, 
2-21 
5.1 ± 3.1, 
0-21 
.66b 
Share personal items, n (%)g 2 (25.0) 31 (8.3) .15 
Shave any body part, n (%) 7 (87.5) 313 (83.5) .76h 
Note. SD = standard deviation. STI = sexually transmitted infection. S. aureus = Staphylococcus aureus.  
a Fisher’s exact test unless otherwise noted 
b Two-sided t-test 
c Other chronic diseases included neurologic, endocrine, musculoskeletal, optic, gastrointestinal, hematologic, and psychological 
diseases. 
d  Chronic skin conditions included eczema, psoriasis, acne, dermatitis, impetigo, and vitiligo 
e Participants were asked if they engaged in this activity in the previous six months. 
f High-risk sexual activity constituted having multiple sex partners and/or being a man who has sex with men. 
g Personal items included towels, clothes, soap, razors, combs/brushes, deodorant, and nail clippers. 




Table 4.4  
 
Demographic, Clinical, and Behavioral Characteristics of HIV- and non-HIV-infected Inmates 
at Bedford Hills Correctional Facility (n=373) 
 
Characteristic HIV  
(n = 19) 
non-HIV 
(n =  354) 
pa 
Mean age ± SD,  
range (years) 
39.4 ± 11.9, 
19-61 
34.8 ± 10.6, 
16-60 
.07b 
Race/ethnicity, n (%) 
  Black 








Education level completed, n (%) 
  Less than high school 








General health, n (%) 
  Excellent or good 










Chronic disease, n (%) 
  Diabetes 
  Cardiovascular 
  Pulmonary 
  Kidney 
  Liver  
  Cancer 

























STI, n (%) 9 (47.4) 79 (22.3) .01 
Chronic skin condition, n (%)e 6 (31.6) 71 (20.1) .23 
Past S. aureus infection, n (%) 2 (10.5) 21 (5.9) .33c 
Systemic antibiotics, n (%)f 6 (31.6) 140 (39.5) .49 
Injection drug use, n (%) 5 (26.3) 40 (11.3) .05 
Sexually active, n (%)f 5 (26.3) 184 (52.0) .03 
Multiple sex partners, n (%)f 1 (5.3) 37 (10.5) .71c 
Average showers per week,  
mean ± SD, range 
8.2 ± 4.5, 
2-21 
8.8 ± 3.9, 
1-21 
.47b 
Share personal items, n (%)g 5 (26.3) 62 (17.5) .15 
Shave any body part, n (%)  7 (36.8) 202 (57.1) .08 
Note. SD = standard deviation. STI = sexually transmitted infection. S. aureus = Staphylococcus aureus.  
a Two-sided  χ2 test unless otherwise noted 
b Two-sided t-test 
c Fisher’s exact test 
d Other chronic diseases included neurologic, endocrine, musculoskeletal, optic, gastrointestinal, hematologic, and psychological 
diseases. 
e  Chronic skin conditions included eczema, psoriasis, acne, dermatitis, impetigo, and vitiligo 
f Participants were asked if they engaged in this activity in the previous six months. 






 The overall prevalence of STIs was 16.3%, which differed significantly between men 
(9.1%) and women (23.6%). Although females comprised 50% of the total sample, they 
accounted for the majority of those with STIs (71.5%). Both male (p = .65) and female subjects 
(p = .53) with and without STIs were equally likely to report being sexually active in the 
previous six months; however, women with STIs were more likely to report having multiple sex 
partners in the same time frame (p = .01). No men who have sex with men (MSM) reported a 
history of STI. Both men and women with STIs were more likely to report the use of antibiotics 
in the previous six months (p < .05), Tables 4.5 and 4.6 compare demographic, clinical, and 





















Demographic, Clinical, and Behavioral Characteristics of Inmates with and without STIs at Sing 
Sing Correctional Facility (n=383) 
 





Mean age ± SD,  
range (years) 
33.5 ± 11.2 
21-63 
33.7 ± 9.3 
17-64 
.88b 
Race/ethnicity, n (%) 
  Black 








Education level completed, n (%) 
  Less than high school 








General health, n (%) 
  Excellent or good 








HIV/AIDS, n (%) 0 8 (2.3) 1.00c 
Chronic disease, n (%) 
  Diabetes 
  Cardiovascular 
  Pulmonary 
  Kidney 
  Liver  
  Cancer 

























Chronic skin condition, n (%)e 13 (37.1) 58 (16.7) .003 
Past S. aureus infection, n (%) 0 7 (2.0) 1.00c 
Systemic antibiotics, n (%)f 11 (31.4) 60 (17.2) .04 
Injection drug use, n (%) 2 (5.7) 18 (5.2) .70c 
Sexually active, n (%)f 6 (17.1) 71 (20.4) .65 
Multiple sex partners, n (%)f 1 (2.9) 22 (6.3) .71c 
Men who have sex with men, n (%)f 0 (0) 11 (3.2) .61c 
High risk sexual activity, n (%)f,g 1 (2.9) 31 (8.9) .34c 
Average showers per week,  
mean ± SD, range 
5.11 ± 3.3 
2-14 
5.1 ± 3.2 
0-21 
.97b 
Share personal items, n (%)h 6 (17.1) 27 (7.8) .06 
Shave any body part, n (%) 32 (91.4) 288 (82.8) .19 
Note. SD = standard deviation. STI = sexually transmitted infection. S. aureus = Staphylococcus aureus.  
a Two-sided χ2 test unless otherwise noted  
b Two-sided t-test 
c Fisher’s exact test 
d Other chronic diseases included neurologic, endocrine, musculoskeletal, optic, gastrointestinal, hematologic, and psychological 
diseases. 
e Chronic skin conditions included eczema, psoriasis, acne, dermatitis, impetigo, and vitiligo 
f Participants were asked if they engaged in this activity in the previous six months. 
g High-risk sexual activity constituted having multiple sex partners and/or being a man who has sex with men. 







Demographic, Clinical, and Behavioral Characteristics of Inmates with and without STIs at 
Bedford Hills Correctional Facility (n=373) 
 





Mean age ± SD,  
range (years) 
35.8 ± 10.4 
18-61 
34.8 ± 10.8 
16-60 
.45b 
Race/ethnicity, n (%) 
  Black 








Education level completed, n (%) 
  Less than high school 








General health, n (%) 
  Excellent or good 








HIV/AIDS, n (%) 9 (10.2) 10 (3.5) .01 
Chronic disease, n (%) 
  Diabetes 
  Cardiovascular 
  Pulmonary 
  Kidney 
  Liver  
  Cancer 

























Chronic skin condition, n (%)e 22 (25.0) 55 (19.3) .25 
Past S. aureus infection, n (%) 4 (4.5)  19 (6.7) .62c 
Systemic antibiotics, n (%)f 44 (50.0) 102 (35.8) .02 
Injection drug use, n (%) 13 (14.8) 32 (11.2) .37 
Sexually active, n (%)f 42 (47.7) 147 (51.6) .53 
Multiple sex partners, n (%)f 16 (18.2) 22 (7.7) .01 
Average showers per week,  
mean ± SD, range 





Share personal items, n (%)h 23 (26.1) 44 (15.4) .02 
Shave any body part, n (%) 32 (91.4) 288 (82.8) .19 
Note. SD = standard deviation. STI = sexually transmitted infection. S. aureus = Staphylococcus aureus.  
a Two-sided χ2 test unless otherwise noted  
b Two-sided t-test 
c Fisher’s exact test 
d Other chronic diseases included neurologic, endocrine, musculoskeletal, optic, gastrointestinal, hematologic, and psychological 
diseases. 
e Chronic skin conditions included eczema, psoriasis, acne, dermatitis, impetigo, and vitiligo 
f Participants were asked if they engaged in this activity in the previous six months. 
g High-risk sexual activity constituted having multiple sex partners and/or being a man who has sex with men. 






Aim 1: Patterns of S. aureus co-infection with HIV or STIs 
 The first study aim was to describe the patterns of S. aureus (MSSA and MRSA) co-
infection with HIV or STIs. S. aureus carriage rates were high in this population. 53.8% of the 
total sample was colonized with S. aureus in the anterior nares and/or the throat with no 
significant differences detected between the two prisons (p = .32). The MRSA colonization rate 
for the total sample was 8.5% (n = 64). Differences in MSSA and MRSA carriage between 
subjects from the two prisons were noted. Men were significantly more likely to carry MSSA 




Staphylococcus aureus Profile of Inmates at Sing Sing and Bedford Hills Correctional Facilities 
(n=756) 
 
S. aureus Total 
(n = 756) 
Sing Sing 
(n = 383) 
Bedford Hills 
(n = 373) 
p* 
Any S. aureus, n (%) 407 (53.8) 213 (55.6) 194 (52.0) .32 
MSSA, n 
     Proportion of total 
sample (%) 





















     Proportion of total 
sample (%) 
     Proportion of S. 
aureus (%) 
64 

















Note. MSSA= Methicillin-susceptible Staphylococcus aureus. MRSA= Methicillin-resistant Staphylococcus aureus. Frequencies 
represent S. aureus carriage in the nares and/or throat. Values calculated for MSSA + MRSA may add up to more than 100% due 
to individuals colonized with both MSSA and MRSA in the nares and throat (n = 7).  





 Among HIV-infected men, 6/8 (75%) had a culture positive for S. aureus in either the 
nares and/or throat as described in Table 4.8. S. aureus carriage was similar between HIV-
infected and uninfected subjects (p = .27) in this group. All men colonized with S. aureus carried 
a methicillin-susceptible strain. Among HIV-infected women, 9/19 (47.4%) had a culture 
positive for S. aureus as illustrated in Table 4.9. A greater proportion of HIV-infected women 
were colonized with MRSA (21.1%) compared to subjects without HIV (11%), but this 
difference was not statistically significant (p = .26).  
Table 4.8  
 
Staphylococcus aureus Profile of Inmates Co-Infected with HIV at Sing Sing Correctional 
Facility (n =383)  
 
S. aureus HIV 
(n = 8) 
non-HIV 




Any S. aureus, n (%) 
 
6 (75.0) 207 (55.2) 2.4 
(.49 - 12.2) 
.27 
MSSA, n 
    Proportion of total 
sample (%) 


















    Proportion of total 
sample (%) 














Note. OR= Odds ratio. CI= Confidence Interval. MSSA= Methicillin-susceptible Staphylococcus aureus. MRSA= Methicillin-
resistant Staphylococcus aureus. Frequencies represent S. aureus carriage in the nares and/or throat. Values calculated for MSSA 
+ MRSA may add up to more than 100% due to individuals colonized with both MSSA and MRSA in the nares and throat (n = 
4). 
a Two-sided χ2 test unless otherwise noted  





Table 4.9  
 
Staphylococcus aureus Profile of Inmates Co-Infected with HIV at Bedford Hills Correctional 
Facility (n =373)  
 
S. aureus HIV 
(n = 19) 
non-HIV 




Any S. aureus, n (%) 
 




    Proportion of total 
sample (%) 


















    Proportion of total 
sample (%) 
















Note. OR= Odds ratio. CI= Confidence Interval. MSSA= Methicillin-susceptible Staphylococcus aureus. MRSA= Methicillin-
resistant Staphylococcus aureus. Frequencies represent S. aureus carriage in the nares and/or throat. Values calculated for MSSA 
+ MRSA may add up to more than 100% due to individuals colonized with both MSSA and MRSA in the nares and throat (n = 
3). 
a Two-sided χ2 test unless otherwise noted  
b Fisher’s exact test 
 
 Of the 123 subjects with a history of STI, 68 (55.3%) were also colonized with S. aureus. 
No statistically significant differences in S. aureus carriage were found between male (p = .22) 
or female (p = .13) subjects with and without STIs. Among subjects positive for S. aureus, 
MSSA colonization predominated among those with STIs and those without STIs. More than 
80% of S. aureus positive samples in men with and without STIs were methicillin-susceptible. 
Statistically significant differences in MRSA colonization were noted between female subjects 
with and without STIs. Women with STIs were greater than two times more likely to be 
colonized with MRSA than those without STIs (OR 2.1, p = .03). The S. aureus profiles of men 





Table 4.10  
Staphylococcus aureus Profile of Inmates Co-Infected with STIs at Sing Sing Correctional 
Facility (n=383)  
S. aureus STI 
(n = 35) 
non- STI 




Any S. aureus, n (%) 
 
16 (45.7) 197 (56.6) .65 
(.32 - 1.30) 
.22 
MSSA, n 
  Proportion of total 
sample (%) 


















  Proportion of total 
sample (%) 















Note. OR= Odds ratio. CI= Confidence Interval. STI= sexually transmitted infection. MSSA= Methicillin-susceptible 
Staphylococcus aureus. MRSA= Methicillin-resistant Staphylococcus aureus Frequencies represent S. aureus carriage in the 
nares and/or throat. Values calculated for MSSA + MRSA may add up to more than 100% due to individuals colonized with both 
MSSA and MRSA in the nares and throat (n=4). 
a Two-sided χ2 test  
















Table 4.11  
Staphylococcus aureus Profile of Inmates Co-Infected with STIs at Bedford Hills Correctional 
Facility (n=373)  
S. aureus STI 
(n = 88) 
non- STI 




Any S. aureus, n (%) 
 
52 (59.1) 142 (49.8) 1.46 
(.90 – 2.36) 
.13 
MSSA, n 
  Proportion of total 
sample (%) 


















  Proportion of total 
sample (%) 















Note. OR= Odds ratio. CI= Confidence Interval. STI= sexually transmitted infection. MSSA= Methicillin-susceptible 
Staphylococcus aureus. MRSA= Methicillin-resistant Staphylococcus aureus Frequencies represent S. aureus carriage in the 
nares and/or throat. Values calculated for MSSA + MRSA may add up to more than 100% due to individuals colonized with both 
MSSA and MRSA in the nares and throat (n=3). 
* Two-sided χ2 test  
 
Aim 2: Risk factors for S. aureus co-infection with HIV or STIs 
 The second study aim was to identify risk factors for S. aureus co-infection with HIV or 
STIs. The small sample of subjects with HIV-S. aureus co-infection (n = 15) prevented the 
fitting of a regression model to determine risk factors for co-infection in this group. Because 
there were significant differences between men and women on several variables of interest, the 
two prison populations  were analyzed separately as noted previously. The small sample of men 
co-infected with STI-S. aureus (n = 16) prevented the fitting of a regression model to determine 
risk factors for STI-S. aureus co-infection in this group. Therefore, a model to identify risk 
factors for STI-S aureus co-infection was only fit for women. Demographic characteristics of 




Table 4.12  
 
Demographic, Clinical, and Behavioral Characteristics of Men Co-Infected with STI-S. aureus at 
Sing Sing Correctional Facility (n=383) 
 
Characteristic STI-S. aureus  
(n = 16) 
No STI-S. 
aureus  
(n = 367) 
pa
Mean age ± SD,  
range (years) 
31.7 ± 6.1 
16-45 
33.8 ± 9.6 
17-64 
.21b
Race/ethnicity, n (%) 
  Black 








Education level completed, n (%) 
  Less than high school 








Previous residence, n (%) 
  Jail 
  Prison 











General health, n (%) 
  Excellent or good 








HIV/AIDS, n (%) 0 (0) 8 (2.2) 1.00c
Chronic skin condition, n (%)d 5 (31.3) 66 (18.0) .18 
Past S. aureus infection, n (%) 0(0) 7 (1.9) 1.00c
Systemic antibiotics, n (%)e 5 (31.3) 66 (18.0) .18 
Injection drug use, n (%) 0 (0) 20 (5.4) 1.00c
Sexually active, n (%)e 5 (31.3) 72 (19.6) .26 
Multiple sex partners, n (%)e 1 (6.3) 22 (6.0) 1.00c
Average showers per week,  
mean ± SD, range 
4.1± 1.8 
2-7 
5.2 ± 3.2 
0-21 
.17b
Share personal items, n (%)f 2 (12.5) 31 (8.4) .64c
Shave any body part, n (%)   16 (100.0) 304 (82.8) .07 
Note. SD = standard deviation. STI= sexually transmitted infection. S. aureus = Staphylococcus aureus.  
a Two-sided χ2 test unless otherwise noted 
b Two-sided t-test 
c Fisher’s exact test 
d Chronic skin conditions included eczema, psoriasis, acne, dermatitis, impetigo, and vitiligo 
e Participants were asked if they engaged in this activity in the previous six months. 
f Personal items included towels, clothes, soap, razors, combs/brushes, deodorant, and nail clippers. 
 
 A total of 52 women were co-infected with STI-S. aureus. Compared to women who 
were not co-infected, these women were more likely to be Black and to have not graduated from 
high school (p < .05). Most reported their health as excellent or good (73.1%). More than 50% 




multiple sex partners during the same time period. Half of the women co-infected with STI-S. 
aureus reported recent antibiotic use and 4% reported having a previous S. aureus infection. Co-
infected women also reported taking more showers per week (p = .02) and sharing more personal 
items (p = .07). Crude odds ratios with associated p values from univariate analyses comparing 
demographic characteristics between women co-infected with STI-S. aureus and those not co-
infected are presented in Table 4.13. 
Variables were selected as potential predictors for multivariate analyses based on 
previous literature and associated theoretical plausibility. Given the sample size of approximately 
50, a conservative approach was taken, and four variables were selected for use in the building of 
a logistic regression model. Variables included were HIV status, systemic antibiotic use, number 
of showers taken each week, and sharing of personal items. Collinearity among the selected 
predictor variables was assessed and neither tolerance values < 0.1 nor variance inflation factors 
> 2.5 was detected, providing no evidence of collinearity. These variables were entered together 
into a binary logistic regression model with STI-S. aureus co-infection as the outcome variable. 
The regression was then adjusted for age, race/ethnicity, and education level. After controlling 
for demographic variables, only average number of showers retained statistical significance in 
the model, such that reporting taking more showers each week was associated with an increased 
risk of having STI-S. aureus co-infection (adjusted OR = 1.08, p = 0.04). The Hosmer and 
Lemeshow’s test was used to assess goodness of fit of this model and was found to be adequate 










Table 4.13  
 
Comparison of Women Co-Infected and Not Co-Infected with STI-S. aureus at Bedford Hills 
Correctional Facility (n=373)   
 
Characteristic STI-S. aureus 
(n = 52) 
No STI-S. 
aureus 




Mean age ± SD,  
range (years) 
33.3 ± 9.6 
18-61 
35.3 ± 10.9 
16-60 
-- .22b 
Race/ethnicity, n (%) 
   Black 










Education level completed, n (%) 
   Less than high school 










Previous residence, n (%) 
   Jail 
   Prison 











General health, n (%) 
   Excellent or good 










HIV/AIDS, n (%) 5 (9.6) 14 (4.4) 2.3  
(.80- 6.78) 
.11 
Chronic disease, n (%) 
   Diabetes 
    
   Cardiovascular 
    
   Pulmonary 
 
   Kidney 
 
   Liver  
 
   Cancer  
    


























































Chronic skin condition, n (%)e 9 (17.3) 68 (21.2) .78  
(.36- 1.68) 
.52 
Past S. aureus infection, n (%) 2 (3.8) 21 (6.5) .57  
(.01-2.51) 
.76c 
Systemic antibiotics, n (%)f 26 (50.0) 120 (37.4) 1.68  
(.93-3.02) 
.08 







Table 4.13 cont’d 
 
Characteristic STI-S. aureus 
(n = 52) 
No STI-S. 
aureus 




Sexually active, n (%)f 27 (51.9) 162 (50.5) 1.06  
(.59-1.91) 
.85 
Multiple sex partners, n (%)f 8 (15.4) 30 (9.3) 1.76  
(.76- 4.09) 
.18 
Average showers per week,  
mean ± SD, range 
10.1 ± 4.1 
3-21 
8.64 ± 3.9 
1-21 
-- .02b 
Share personal items, n (%)g 14 (26.9) 53 (16.5) 1.86  
(.94-3.68) 
.07 
Shave any body part, n (%) 
   
   Arms 
   
   Legs 
 
   Torso 
 
   Crotch 
 
   Face 
 
   Underarms 
 





























































Note. OR = odds ratio. CI = confidence interval. SD = standard deviation. STI= sexually transmitted infection. S. aureus = 
Staphylococcus aureus.  
a Two-sided χ2 test unless otherwise noted 
b Two-sided t-test 
c Fisher’s exact test 
d Other chronic diseases included neurologic, endocrine, musculoskeletal, optic, gastrointestinal, hematologic, and psychological 
diseases. 
e Chronic skin conditions included eczema, psoriasis, acne, dermatitis, impetigo, and vitiligo 
f Participants were asked if they engaged in this activity in the previous six months. 











Table 4.14.  
Multivariate Logistic Regression Results for STI-S. aureus Co-Infection Among Women at 


































mean ± SD, 
range 
 







items, n (%) 





Note: OR= Odds ratio. CI= confidence interval. STI= sexually transmitted infection. S. aureus= Staphylococcus aureus. Adjusted 
OR was adjusted for age, race/ethnicity, and education level  
 
Summary 
 In this sample of inmates at Bedford Hills (n = 373) and Sing Sing (n = 383) prisons, S. 
aureus carriage was high (53.8%). Among men, co-infection of S. aureus with HIV and STIs 
was 75% and 45.7%, respectively. Among women, co-infection of S. aureus with HIV and STIs 
was 47.4% and 59.1%, respectively. Multivariate analysis revealed that reporting taking more 
showers each week was significantly associated with increased risk of having STI-S. aureus co-





Chapter 5: Discussion and Implications 
Introduction  
STIs and HIV and have been identified as predictors of S. aureus infection in community 
and incarcerated populations, respectively (Hota, et al., 2007; Lee, et al., 2005). However, no 
literature to date has specifically enumerated the occurrence of S. aureus co-infection with HIV 
or STIs in this setting. Thus, the aims of this study were to describe the patterns of S. aureus co-
infection with HIV or STIs and to identify risk factors for co-infection in two New York State 
prisons. This chapter will outline and discuss the results of the investigation. Limitations of the 
study, clinical and policy implications, and proposals for future research are also discussed.  
Demographic Findings 
 This cross-sectional, descriptive, correlational secondary analysis consisted of a 
convenience sample of 373 women from Bedford Hills and 383 men from Sing Sing 
Correctional Facilities in New York. The prevalence of HIV/AIDS in the sample was 3.6% and 
women were more likely to be HIV-infected than men. The HIV prevalence rate was lower than 
the 5.8% reported for New York State prisons by the U.S. Department of Justice (2009). 
According to Kahn and colleagues (2006), the prevalence of selected STIs in correctional 
facilities ranged from 1.4 – 7% in men and 2.6 – 8.5% in women. Rates of STIs in this sample 
were elevated at 9.1% for men and 23.6% for women. All women entering prisons in New York 
are screened for syphilis, gonorrhea, chlamydia, and given PAP smears, which likely accounts 
for the high rates of STIs in women found in this sample. Men, however, are only routinely 
screened for syphilis; this routine screening may explain why syphilis was the second most 





Aim 1. Patterns of S. aureus Co-infection with HIV or STIs 
 The first aim of this study was to describe the patterns of S. aureus co-infection with HIV 
or STIs in two prison populations. Results of this study revealed elevated rates of nasal and 
throat S. aureus carriage in both prisons (53.8%), which was similar between Sing Sing (55.6%) 
and Bedford Hills (52%). Previous research in the same prisons reported a S. aureus nasal 
colonization rate of 25.5% (Lowy, et al., 2007). However, researchers in the previous study 
cultured only the nares, whereas the current study cultured both the nares and throat. Further 
analyses examining site of S. aureus colonization revealed that 26%, 41%, and 33% of the 
sample was colonized in the nares only, throat only, and at both sites respectively. This finding 
of 26% nasal colonization is consistent with the previous research. Moreover, the high throat 
colonization rate supports recent findings identifying the throat as an important reservoir for S. 
aureus colonization and a potential area for continued study and intervention as throat culture 
may enhance S. aureus detection (Hamdan-Partida, et al., 2010; Lee, et al., 2011; Marshall & 
Spelman, 2007; Nilsson & Ripa, 2006).  
 Of all S. aureus isolates, 15.7% were methicillin resistant. Significant differences in 
methicillin resistance patterns were identified between male and female subjects. Women were 
more likely to be colonized with a methicillin resistant strain and men were more likely to be 
colonized with a methicillin susceptible strain. A similar trend was identified in the Texas prison 
system where women were nearly twice as likely as men to develop MRSA infections 
(Baillargeon, et al., 2004) as well as in a Mississippi prison during a MRSA outbreak (Centers 
for Disease Control and Prevention, 2001). Using a nationally representative sample of non-
institutionalized persons, Kuehnert and colleagues (2006) also found a positive association 




MRSA among females are lacking in the current literature. In the current study, differences in 
MRSA carriage rates may be further obscured by the fact that women and men entering these 
facilities come from very different settings i.e., other jails vs. prisons. It is possible that the 
differences in previous residence may be mediating the apparent gender differences. Moreover, 
higher antibiotic use by women in the current sample may help to explain some of the elevation 
in MRSA in this group; however, the study design limits examination of this speculation as 
information regarding the temporal relationship between antibiotic use and MRSA colonization 
was not obtained.  
  Among HIV-infected men, 6/8 (75%) had a culture positive for S. aureus in either the 
nares and/or throat, but no significant differences were found between HIV-infected and 
uninfected subjects. Of men positive for S. aureus, none carried a MRSA strain. S. aureus 
carriage rates were also similar between HIV-infected and uninfected women. Although MRSA 
carriage rates among HIV women was high (21.1%), no significant difference was found in 
comparison to those not infected with HIV (11%). Therefore, the hypothesis that rates of S. 
aureus colonization would be higher in the HIV-infected compared to those not infected with 
HIV was not supported. The small HIV-infected sample size may be partially responsible for this 
finding as there was not sufficient power to detect differences between the two groups. Although 
MRSA carriage rates among HIV-infected subjects was high, no significant difference was found 
in comparison to those not infected with HIV. Interpretation of this non-significant result is 
likely limited due to the small number of HIV-infected subjects with MRSA (n = 4). The effect 
of the small sample is evident in the wide 95% confidence interval (0.68-6.8) for the odds ratio. 
A larger prison study (n = 4663) reported a nearly three-fold increase in the likelihood of having 




(n = 162) found no increase in MRSA risk among HIV-infected inmates (n = 8) (Maree et al., 
2010). While other study-specific factors may be involved, some of the inconsistency in results 
across these studies can reasonably be attributed to differences in sample size.  
 No statistically significant differences in S. aureus carriage were identified between men 
with and without STIs in this sample. However, a greater proportion of men with STIs were 
colonized with an MRSA strain. Rates of S. aureus colonization were similar between female 
subjects with and without STIs at 59.1% and 49.8%, respectively. However, women with STIs 
were significantly more likely to be colonized with MRSA compared to those without STIs. 
Several factors may be acting to influence these findings. Again, the differences in gender and 
previous residence are evident, although it is not possible in the current study to determine which 
factor is exerting the true influence. Additionally, as 45% of those with STIs reported recent 
antibiotic use, it is possible that some of these individuals were prescribed antibiotics to treat an 
STI, which subsequently made them more susceptible to developing MRSA. Temporality could 
not be established because reliable data as to when a specific antibiotic was prescribed was not 
available. Research relating STI and S. aureus is limited and focuses on sexual risk behavior in 
HIV-infected individuals. Lee, et al (2005) found multiple sex partners and recent STI to be 
significantly associated with MRSA skin infection in univariate analysis among community-
dwelling, HIV-infected men who have sex with men (MSM); however, neither retained 
significance in multivariate analysis. No studies linking STIs and S. aureus in a prison or jail 
setting were identified in the literature.  
While the hypothesis that S. aureus rates among subjects with STIs would be higher than 
rates among those without STIs was not supported, it is clinically important that, among women, 




use may prove useful in further evaluating the likely role of sound antimicrobial stewardship in 
preventing MRSA spread within the community as well as in closed settings, such as prisons and 
jails. The Federal Bureau of Prisons (2011) recommends first-line use of TMP-SMX for mild-
moderate cases of MRSA SSTIs in prison settings. 
 Statistically significant differences in S. aureus carriage rates between subjects with and 
without HIV-infection or STIs was not supported by the data. However, several others findings 
are noteworthy. The data suggest that rates of S. aureus colonization may be uniformly elevated 
in corrections settings. The 41% throat colonization rate, when combined with mounting 
evidence of the role of throat colonization in S. aureus identification, may have important 
implications in future S. aureus surveillance studies. Furthermore, risk factors for STIs and HIV, 
e.g., high-risk sexual activity and injection drug use (IDU), are common in prison populations, 
even among those without STIs and HIV. It is plausible that the prevalence of these behaviors 
across groups made it difficult to detect increased risk of S. aureus specifically among subjects 
with STIs and HIV. 
Aim 2. Risk factors for S. aureus co-infection with HIV or STIs  
 The second study aim was to identify risk factors for S. aureus co-infection with HIV or 
STIs in the two prisons. Limited sample size prohibited the fitting of regression models to 
identify risk factors for HIV-S. aureus (n = 15) and STI-S. aureus in men (n = 16).Therefore, a 
risk model was only fit for women co-infected with STI-S. aureus.  
In multivariate analysis, controlling for age, race/ethnicity, and education level, average 
number of showers taken each week was significantly associated with STI-S. aureus co-
infection. Subjects who reported taking more showers each week were more likely to be co-




factor for co-infection, the direction of the association is inconsistent with previous literature. In 
multivariate analysis, Maree and colleagues (2010) found daily showering to be protective 
against MRSA colonization in a corrections setting. Indeed, numerous investigations have 
identified inadequate hygiene, including limited access to showering, as a facilitator of MRSA 
spread in prisons (Aiello, et al., 2006; Bick, 2007; Centers for Disease Control and Prevention, 
2001; Centers for Disease Control and Prevention, 2003a, 2003c). Given the current sample, it is 
possible that women may take more showers as a result of their STI symptoms, e.g., vaginal 
discharge. This hypothesis may be even more reasonable if indeed these women acquire MRSA 
as a result of antibiotic use to treat STIs. If this were the case, we would expect elevated MRSA 
rates to persist in the presence of adequate hygiene practices, such as frequent showering. This 
possibility, however, is speculative as we were not able to analyze such a hypothesis with the 
data collected. Further investigation in this area is warranted to accurately examine and explain 
this relationship.   
Relationship of Findings Conceptual framework 
 The vulnerable populations model for health-related research developed by Flaskerud & 
Winslow (1998) was the conceptual framework used to guide this study. The model 
conceptualizes relationships between resource availability, relative rids, and health status in 
groups considered to be vulnerable to comparatively poorer health outcomes than the general 
population. The model was modified for the particular case of S. aureus, STIs, and HIV in 
prisons and the current inquiry aimed to address the relationship between relative risk and health 
status. Specifically, the study examined the extent to which poor health status, operationalized as 
STI and HIV infection, in a high risk prison environment is associated with other negative health 




experienced high rates of S. aureus colonization. However, these individuals’ increased 
vulnerability for carrying S. aureus compared to other prisoners was not supported by the data as 
evidenced by non-significant differences in S. aureus carriage between subjects with and without 
STIs and HIV.   
Study Limitations 
 There were several noteworthy limitations to this study that must be considered when 
interpreting and applying the results. These limitations include threats to validity, 
generalizability, and inadequate power.  
The cross-sectional nature of this study limits interpretation of the results. Because 
causality cannot be inferred based on the associations identified, the temporal direction of the 
relationships is unknown. Antibiotic use was common in the STI sample; however, it was not 
known whether antibiotic use preceded the STI diagnosis. 
There are also limitations related to internal validity as a result of using a self-report 
interview. Recall bias was a concern in asking participants to remember activities within a 
certain time frame, such as in the past six months. It is also possible that some participants failed 
to report certain behaviors, such as IDU, due to social desirability. If underreporting of risk 
factors occurred frequently, then it may be that the observed results were conservative estimates. 
We attempted to reduce recall bias by including a medical record review as additional method of 
validation for the interview responses. However, this process proved useful primarily in 
obtaining laboratory results for STIs since inconsistent collection of self-report items, e.g., sexual 





Non-random, convenience sampling was used, which threatened generalizability. 
Because no data were collected for those prisoners who refused to participate, it is not certain 
that they were similar to those who participated. Moreover, only two prisons in New York State 
were sampled. Our sample was generally younger than the populations in both facilities. The 
sample from Bedford Hills was less educated than the overall female population of state prisons. 
However, in the comparative analyses, we adjusted the model for these variables to control for 
these differences. 
An a priori power analysis was conducted and noted that this secondary analysis was 
underpowered to detect differences in S. aureus colonization between groups of subjects with 
HIV and STIs (Table 3.3). Interim data from the parent study found a higher than expected S. 
aureus carriage rate (~50%); consequently, the targeted total sample size was reduced from 910 
to 800. Upon completion of the analysis, an a posteriori power analysis was conducted to 
determine the true power of this secondary analysis. Given the following sample sizes: 
ntotal=756, nHIV = 27, nSTI = 123, prevalenceS. aureus = 0.5, the calculated power for HIV = .058 and 
for STI = 0.075. The severely limited power greatly hindered the ability to detect differences as 
the chi-square statistic used to analyze the categorical data is heavily influenced by sample size. 
Low statistical power increases the likelihood of finding statistically non-significant results. 
Interpretation of such results is inconclusive because it is possible that a difference between 
measured groups existed, but was not detected, i.e., a type II error occurred. Sufficient numbers 
of subjects with and without the variables of interest were not obtained in this study. In this 
secondary analysis, it was not possible to control the power obtained since the total sample size 






 This study revealed high levels of S. aureus carriage in two New York State prisons. 
Several implications for practice, policy, and future research emerged in light of these findings 
and the aims of the study.  
Practice implications. The literature suggests that nurses working in corrections 
are often conflicted in their dual roles as custodians and caregivers (Watson, et al., 2004). This 
conflict may manifest most clearly in the case of maintaining adequate infection prevention 
strategies in prisons. 
Nurses can play a critical role in the early identification and treatment of S. aureus 
infections in prison settings. The threshold for suspicion for S. aureus infection should be 
lowered in this setting with markedly high rates of carriage. As the gatekeeper to health services, 
it is primarily the nurse’s duty to be vigilant in identifying potential infections and referring 
inmates to appropriate medical staff to ensure timely treatment, thereby minimizing the risk of 
transmission.  
Creative strategies that maximize infection prevention measures and minimize threats to 
safety require collaborative efforts to engage staff, policymakers, as well as prisoners. Previous 
interventions to reduce MRSA transmission in prisons involved an educational component for 
prisoners (Centers for Disease Control and Prevention, 2003a). Patient education is an essential 
nursing function and should not be neglected, regardless of the population being served. Nurses 
can take advantage of their frequent contact with inmates to develop educational sessions 
surrounding infection control and realistic hygiene strategies that can be implemented in the 




excellent opportunity for nurses to engage in their roles as advocates for staff and inmates to 
potentially make tangible impacts on health outcomes. 
Policy implications. Any policy relating to the provision of healthcare must be 
informed by sound, clinically-relevant research. Prisoners have a constitutional mandate 
guaranteeing healthcare services (Estelle v. Gamble, 1976), and are considered a vulnerable 
research population. Therefore, it may be difficult for outside researchers to access correctional 
facilities. Researchers have documented the ethical and regulatory challenges inherent in prison 
research, as well as approaches that can be taken to overcome these challenges (Byrne, 2005; 
Brewer-Smith, 2008). An interdisciplinary, collaborative approach to research and policy 
recommendations in which all vested interests, e.g., prison administrators, staff, and prisoners are 
key players is essential (Byrne, 2005). Moreover, the primary role of prisons is containment and 
security; therefore, maintaining safety is of paramount importance. As a result, current practices 
in correctional facilities restrict access to critical supplies necessary to prevent transmission of 
infections, such as bleach for laundering and alcohol-based hand sanitizers. Such supplies are 
considered potential safety hazards as they can readily be used to cause injury to other inmates 
and staff (Bick, 2007).  These considerations must be taken into account by researchers when 
making policy recommendations to administrators who must maintain balance in preventing the 
spread of disease and lessening the potential for harm to staff and inmates. The Federal Bureau 
of Prisons (2011) provides guidelines for the management of MRSA in prison settings, which 
outlines practical steps to be taken to prevent, identify, and treat MRSA in these settings.  
Colonization with S. aureus, and MRSA specifically, is often a precursor to clinical 
infection, although most colonized individuals do not progress to infection (Miller, et al., 2003). 




preventing S. aureus infection and is not recommended in healthcare settings (Gorwitz, et al., 
2006). Therefore, a universal screening program may not be the most effective way to curb the 
spread of S. aureus despite the high carriage rates in prisons. Instead, prison administrators and 
infection control staff should be committed to implementing and enforcing measures that reduce 
the risk of S. aureus transmission. In response to MRSA outbreaks, correctional facilities across 
the country have had success in reducing the incidence of MRSA. This success has been due, in 
part, to implementing non-clinical changes, such as hygiene education and more frequent laundry 
changes for inmates (Centers for Disease Control and Prevention, 2003a; Wootton, et al., 2004). 
If consistent implementation of these changes results in a decline in S. aureus carriage rates, the 
cost-effectiveness of the changes should also be assessed to ensure a reasonable allocation of 
resources. Although cost should not be the primary driving factor in studious infection control 
policies, it is a necessary consideration when fiscal and human resources are limited. 
This study’s results also support the institution of routine screening for STIs for men 
upon entering the corrections system. Women tend to have higher rates of STIs, primarily 
because they seek care for symptoms, whereas men with STIs are often asymptomatic although 
they remain infectious (Centers for Disease Control and Prevention, 2009c). For some men in the 
community who have frequent contact with the criminal justice system, correctional facilities 
serve as their only source of primary care. Therefore, diagnosis and treatment for STIs upon 
entry to the system would serve as both a corrections and public health initiative by capturing an 
otherwise hard to reach population for health interventions.  
Future research implications. This study addressed the co-infection status of 
inmates newly entering two prison facilities. Consequently, the results are not reflective of 




respondents reported their most recent residence as another correctional facility, it may still be 
that facility-level dynamics are influencing S. aureus colonization rates among prisoners with 
HIV or STIs. Studies examining colonization rates in prisoners upon discharge from their current 
facility will shed light on potential facility-specific factors that may facilitate or impede 
transmission of S. aureus. Intervention studies, targeting amendable risk factors within the 
prisons can then be individually crafted based on prison-specific factors. Social networking 
analyses examining prisoner contacts and location within the prison may identify deficiencies in 
infection control practices that are contributing to the persistently elevated rates of S. aureus. It 
should be noted, however, that the often abrupt transfer of inmates between facilities may limit 
the feasibility of following specific inmates over time. Federal guidelines do, however, 
recommend that inmates who have been identified with MRSA not be transferred to other 
facilities until they have completed their course of treatment (Bureau of Prisons, 2011). 
A complex interaction across the community, individuals who come into contact with 
correctional facilities, and the physical facilities themselves exists. Some researchers suggest 
simply that individuals acquire MRSA in prisons and transmit it back into the community upon 
release (Skiest, et al., 2006). Okano and Blower (2010), however, offer a more sophisticated 
model of S. aureus transmission within the Los Angeles County Jail and back into the 
surrounding community. Their model accounts for the increased likelihood of MRSA spread 
within prisons due to overcrowding, which increases the frequency of an infected person 
contacting other inmates and transmitting MRSA. In this way, the jail acts as an “amplification 
zone” for MRSA spread since the infected inmate arriving in the prison would not likely have 
had close contact with as many individuals had he not been incarcerated. Network modeling 




investigate the proposed interactions in this model which could be useful in managing the spread 
of S. aureus in both correctional settings and the community. 
Future research into S. aureus colonization patterns among prisoners with HIV and STIs 
should build on results of the current study by addressing the methodological flaws to improve 
rigor and strengthen the validity of any observed findings. A major limitation of the current 
inquiry was inadequate sample size of subjects with HIV or STIs, which limited power. A 
primary analysis, adequately powered to study similar aims as the current investigation could be 
undertaken. Future inquiries should also attempt to access more objective patient data. This may 
be challenging for newly arriving inmates, as we found that much of the history provided in the 
medical record at intake is based on the inmate’s self-report. However, treatment records are 
more complete when the inmate is seen in the prison’s medical facility for care. Therefore, a 
prevalence study, limited to inmates who have been in the same facility for at least six months, 
could provide richer medical data.  
Conclusion 
 Results of this cross-sectional, correlational secondary analysis revealed markedly 
elevated rates of S. aureus carriage in the two prisons studied. Previous research has examined 
HIV as in independent predictor of S. aureus in prisons, but has not examined the risk factors 
associated with co-infection as an outcome. This was the first study to specifically examine the 
prevalence and risk factors for HIV-S. aureus and STI-S. aureus co-infection in prisons in a non-
outbreak setting. Although not statistically significant, co-infection with HIV or STIs among 
those colonized with S. aureus was high. Prisons represent a restrictive environment, where 
individuals are frequently in close physical contact, thereby increasing the likelihood of S. 




needed to identify transmission dynamics and more clearly elucidate opportunities for prevention 
and intervention. Despite methodological weaknesses, the study is relevant prisons and prisoners 
in attempting to identify and control the spread of infectious disease and provides a basis for 
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